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ABSTRACT 
 
Anti-inflammatory drugs can suppress or prevent chronic inflammation. However, 
uncontrolled application of anti-inflammatory drugs often impair the wound healing process. 
This can be overcome by combining hydrogel wound dressings with drug delivery systems to 
achieve stage-dependent drug release. 
The pH of cutaneous wounds is dynamic and correlates with the stage of the wound 
healing process, with inflammation being acidic, granulation being progressively alkali, and 
remodeling returning skin to its pre-injury pH. By taking the advantage of this pH difference, 
stage-specific wound treatments can be developed to respond to these environmental cues 
using a pH sensitive hydrogel. In the first part of this study, pH sensitive methacrylated 
chitosan (MAC) hydrogels were synthesized and characterized through 1H NMR. Chitosan 
was first methacrylated and then crosslinked through three polymerization methods: step 
growth by thiol-ene photoclick reaction, chain growth by UV polymerization, and mixed 
model in which both step growth and chain growth mechanism were used. The resulting 
hydrogels exhibited adjustable mechanical properties, swelling ratios, and pH sensitivities 
without affecting degradation behavior and in vitro cell response. Cytocompatibility studies 
were performed using NIH/3T3 fibroblasts. Cell proliferation was suppressed when seeding 
on the hydrogel surfaces comparing to tissue culture plastic (TCP), yet no measurable cell 
death was observed.  
With appropriate drug delivery systems, the responsivity of these gels to different pH 
environments may prove useful as stage-responsive wound dressings. However, the 
therapeutic effects of many modern drugs are limited owing to their low solubility and low 
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half-life in circulation. Furthermore, there is a lack of design principles which adds the 
difficulty in synthesize efficacious drug carriers. The purpose of the second part of this study 
is to examine the relationship between drug delivery to cells and the chemical properties of 
the polymer micelle drug carriers.  
Polyethylene glycol (PEG) based alternating copolymer poly[(polyoxyethylene)-oxy-
5-hydroxyisophthalic] (Ppeg) with PEG molecular weights of 600 and 1000 were synthesized 
and modified with different alkanes to study the effects of altering the hydrophobic and 
hydrophilic chain lengths. NMR, critical micelle concentration (CMC), micelle size, and 
micelle zeta potential of the synthesized polymers were measured. The resulting polymer 
particles were able to form micelles in aqueous solution with CMCs lower than 0.04 wt%. 
Drug delivery studies were performed with a model hydrophobic drug, pyrene. Drug loading 
data showed the polymer particles were able to encapsulate pyrene and has a loading capacity 
up to 8 wt%. The sustain release ability was measured and the pyrene release was extended 
over 5 days. Both loading capacity and sustain release ability were found to be highly 
dependent on CMC. The micelles were exposed to RAW 264.7 cells to determine their 
cytocompatibility, Most Ppeg polymer micelles showed more than 85% cell viability with 
and without pyrene loading. Cell internalization of the micelles encapsulated drug was 
measured both quantitatively and qualitatively and was enhanced compared to 
unencapsulated drug. Predictive equations of drug loading, releasing, and internalization 
were obtained by factorial analysis as a function of PEG and alkane chain length. The results 
indicated that the internalization enhancement of polymer micelle was mainly affected by 
hydrophilic chain length; neither hydrophobic chain length nor loading capacity has 
significant influence on internalization. 
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CHAPTER I 
INTRODUCTION  
 
Commonly used wound dressing, such as Band-Aids and gauze, can staunch bleeding 
and prevent infection.1 In drug delivery, an active pharmaceutical ingredient is delivered to 
diseased or damaged tissues by various administration routes and modified pharmaceutical 
dosage forms.2 Bioactive wound dressings can be synthesized by combining wound dressing 
with controlled drug delivery, which can sustainably deliver drugs to the wound site and 
accelerate healing.1,3 
Wound Healing Process 
Classical wound healing  can be divided into four continuous stages: hemostasis, 
inflammation, proliferation, and remodeling.1 The first stage, hemostasis, occurs shortly after 
injury and is initiated clotting mechanisms. Fibrinogen and platelets in the exudate cause 
blood clotting and form a fibrin network.3,4 The second stage, inflammation, starts once the 
bleeding is stopped. The fibrin network provides a scaffold for neutrophils infiltration, which 
is induced by complement activation, platelet degradation, and bacterial infection. These 
neutrophils recruit monocytes, which differentiate into macrophages after 2-3 days and the 
necrotic tissues are enzymatically degraded into yellowish liquid also known as pus.3,5 The 
third stage, proliferation, is also refer to tissue regeneration, which usually occurs 2-10 days 
after injury. In this stage, epithelial cells and fibroblasts migrate into the wound site to 
promote angiogenesis and replace fibrin matrix with granulation tissue which formed by 
capillaries and lymphatic vessels.3 This angiogenesis process is regulated by vascular 
endothelial growth factor (VEGF) and fibroblast growth factor 2 (FGF 2). Then, fibroblasts 
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differentiate into myofibroblasts by macrophages, bring the edges of wound together and 
produce collagen to bridge the wound.5 The final stage, remodeling, lasts from weeks to 
years. During this stage, the cells activated in previous stages start to apoptosis or migrate out 
the wound site. The connective tissue is generated and collagen fibers are reconstructed from 
type III collagen to type I collagen by matrix metalloproteinases.  
The wound healing can be affected by many factors. Both physical conditions and 
medical intervention can affect wound healing. Physical conditions such as age, obesity, and 
disease status are known to impede wound healing through dysfunction in fibroblasts and 
macrophages.4 Anti-inflammatory medications, both glucocorticoid steroids and non-
steroids, are commonly applied after injury or surgery to prevent inflammation. However, 
most of anti-inflammatory drugs are found to suppress wound healing by exerting an anti-
proliferative effect.4 Although anti-inflammatory drugs can prevent chronic inflammation, 
the anti-proliferative effect limits its application in wound healing.  
pH Sensitive Hydrogel 
pH sensitive hydrogels have environmentally responsive drug release and/or 
degradation ability.6,7 The hydrogels generally have functional groups that can be protonated 
or deprotonated, such as carboxyl, phosphate, or amino groups. When the environmental pH 
is higher than the functional group’s pKa, a proton will  dissociate and increase or decrease 
hydrophobicity.8 Because of this hydrogen bond strength difference, pH sensitive hydrogel 
can exhibit different chemical and mechanical properties.   
Currently, most pH sensitive hydrogels have focused on oral drug release, which aims 
at minimize swelling and release in the stomach while maximize swelling in the intestinal 
tract to maximize the amount of drug that crosses the intestinal barrier.9–13 For these 
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applications, alginate based hydrogels have been extensively studied. Alginate contains 
carboxylic acid groups, which ionize to -COO- at high pH and reduces hydrogen bonding 
between polymer molecules, thus enhancing electrostatic repulsion between carboxylate 
groups, and increasing the H+ concentration inside gel. All of these factors increase swelling 
at high pH.14   
Chitosan hydrogels have also been used in pH controlled drug delivery and tissue 
engineering. Chitosan is a polysaccharide that naturally exists in crustaceans. It is the only 
cationic natural polymer currently known.15 Being cationic allows chitosan based hydrogels 
to shrink under alkali environment while swell in acid condition due to their amino groups.10 
Although chitosan is not naturally exist in the human body, it is structurally similar to 
cellulose and it is biocompatibility.16 Chitosan is biodegradable by several human enzymes, 
especially lysozme.17 It was often blended with alginate to form an ionically-crosslinked 
hydrogel for pH-sensitive drug release.12 
Hydrogels are often used as bioactive wound dressings. Passive wound dressings are 
designed to staunch blood flow and prevent infection.1 Bioactive wound dressings can 
release growth factors, antibacterial agents, corticosteroids, and other drugs designed to aid 
in chronic wound healing.1 By taking advantage of pH changes during wound healing, ‘smart 
wound dressings could be created using pH sensitive hydrogels, which could yield stage-
specific treatment and significantly accelerate wound healing.   
Drug Delivery 
Many peptides and small molecule drugs suffered from low water solubility, short in 
vivo half-life, and hydrolysis18–20. Rapid in vivo clearance of drugs will further lead to 
targeting issues since passive targeting requires enhanced circulation time in order to increase 
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the possibility for the drug molecule to accumulate in the target tissues21. For instance, the 
hydrophobic drug indomethacin, an anti-inflammatory drug commonly used for rheumatoid 
arthritis, is limited by solubility and has a plasma half-life time of 4.5 h in adults22. Other 
hydrophobic drugs such as anticancer drug paclitaxel, has dose-limiting toxicity and a short 
in vivo half-life time, which, as a result, requires frequent drug administration to maintain 
effective concentration23.  
Moreover, for hydrophobic drugs, oral administration sometimes is not appropriate 
for acute situations owing to the long oral absorption time, and thus intravenous 
administration is required. Due to the solubility limit, cosolvents are often added for injection 
needs24–26. Oftentimes the cosolvent could be toxic, as is the case of the antiarrhythmic drug 
amiodarone,27 which is generally delivered orally but is often combined with hydrochloride 
acid as amiodarone hydrochloride for emergency injection treatment. Nifedipine, a 
cardiotonic, is usually solubilized in glycerin, polyethylene glycol (PEG), and peppermint oil 
mixture24. Other solvents such as ethanol, propylene glycol, and even DMSO24 are often used 
as cosolvents. Side effects such as pain, hemolysis, and irritation commonly occur because of 
the non-biocompatible cosolvent28.        
These disadvantages could be remedied by using appropriate drug delivery 
vehicles.24,29 According to differences in physical and chemical properties, such as solubility 
and in vivo half-life, each drug requires a suitable delivery technique to be delivered into 
targeted tissues2. 
It has been reported that the solubility of indomethacin could be significantly 
enhanced by a poly(amidoamine) dendrimer drug delivery system. Preclinical studies also 
indicated that the terminal half-life time was extended from 2.9 h to 5.0 h in rats30. The 
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micellular drug vehicle Genexol-PM has also been developed for paclitaxel delivery. Clinical 
studies have shown Genexol-PM increased the half-life time of paclitaxel from 5.8 h to 12.7 
h23. Synthetic polymers with biocompatibility have long been developing for the needs of 
drug delivery.31 Nanoparticles, especially those can self-assemble under certain driving force 
such as pH and solvent polarity, are particularly useful as drug delivery vehicles 32.    
Surfactants and their Micelle Structure 
Surfactants are defined as substances that can significantly change the interfacial state 
of a solution system; they contain both hydrophilic and lipophilic groups, giving them an 
amphipathic structure33. Surfactants, particularly bio surfactants, present an attractive 
possibility for drug delivery owing to their biodegradability and chemical sensitivity to 
temperature and pH34. Base on the hydrophilic-lipophilic balance (HLB), surfactants can be 
used as solubilizing agents, detergents, emulsifying agents, spreading agents, and 
antifoaming agents35.  
Performance of the surfactant is highly dependent on the HLB value. Increasing the 
length of the lipophilic group will decrease the surfactant’s water solubility and increase its 
tendency towards aggregation.35,36 In drug delivery, the ability to solubilize hydrophobic 
drugs is one of the largest concerns, which requires a high hydrophilic to lipophilic ratio.  
Polymeric surfactants, especially block or graft copolymers, are well known for their 
unique structure and drug entrapment capability. Due to the amphiphilic nature of the 
surfactants, hydrophobic drugs can be encapsulated in a micellular form.37 Micelles are 
organized via auto-assembly38  and are considered highly efficient drug carriers39 owing to 
their cell membrane-like structure that can enhance internalization.  
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At low concentrations, surfactants are normally orientated on the interface with the 
hydrophilic group facing the aqueous media and the hydrophobic groups facing out to 
minimizing the surface free energy33,36; however, when the surfactant concentration increases 
to a specific value which saturates the interface, the excess surfactant will aggregating into 
core-shell structure with hydrophobic groups directed toward the interior and hydrophilic 
groups toward the solvent in order to reducing free energy40. This specific concentration is 
defined as the critical micelle concentration (CMC)36. The CMC is not only the critical point 
for micelle formation, but also the transition point for solution properties such as surface 
tension, osmotic pressure, conductivity, and particle size (Fig. 1). Generally, the CMC is 
affected by the solution temperature and decreases with the increasing hydrophobicity36,40.  
In hydrophilic solvents such as water, with the presence of organic material and small 
hydrophobic particles, hydrophobic groups of the surfactant will tend to adsorb on the 
particle surface with the hydrophilic groups of the surfactant facing toward solvent to reduce 
free energy40,41. As a result, the particles will be encapsulated by surfactants and form a 
micellular structure42. Because of this, the CMC is one of the most important indicators for 
the ability of a polymeric surfactant to encapsulate drug.  
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Figure 1. Micelle formation upon CMC and a plot of solution properties versus surfactant 
concentration 
Polyethylene Glycol 
PEG is well known for its biocompatibility, high water solubility, and in vivo 
chemical stability43. PEG is relatively bio inert, owing to its ability to inhibit protein 
adsorption and therefore suppress cell attachment.44 It has been reported that drugs loaded in 
PEG coated particles or PEG-like polymers can extend in vivo circulation time by abrogating  
opsonization45. Through appropriate synthetic routes, PEG could be fabricated into polymer 
surfactant32. PEGylated self-assembling drug carriers has been used as a pharmaceutical 
product for decades. One such development is the first FDA-approved nano-drug, Doxil®. 
Doxorubicin was loaded in PEGylated nano liposomes developed by LTI in the early 90s. 
This technique successfully increased doxorubicin’s in vivo half-life time to 90 h46 from 5 
min47,48 . Several efficient copolymer preparation methods have been developed using PEG 
C<CMC     C=CMC                    
CMC                                 
Cond
Surface 
Osmotic 
Interfac
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as a polymeric block49–52. One such development is the stannous octoate catalyst, which is 
often used in PEGylated polymerization reactions. Many widely used polymers such as 
Poly(3-hydroxybutyrate-co-4-hydroxybutyrate) (P3/4HB)53, poly(lactide-co-glycolide) 
(PLGA)54 and polycaprolactone (PCL)55 could react with PEG in the presence of stannous 
octoate to form self-assemble block copolymer. Biocatalyst novozyme 435 was also found to 
be highly effective in mediating dimethyl isophthalate and PEG condensation reactions.32 
Macrophages 
Macrophages are a type of white blood cell that differentiate from monocytes, which 
developed from hematopoietic stem cells56. Macrophages are found in almost all  tissues and 
have tissue dependent behavior57. They play an important role in innate and adaptive 
immunity, along with tumor angiogenesis and metastasis58. Macrophages are well known for 
their highly specialized phagocytic ability, which aids in removing dead cells, pathogens, and 
digesting drug particles. Particle size less than 10µm are efficiently internalized through 
phagocytosis.59 Macrophage phagocytosis typically includes the following steps: (1) 
recognition of particles or pathogens by phagocyte surface receptors; (2) particles are 
phagocytized; (3) particles are trapped in a phagosome; (4) phagolysosome formation by 
phagosome and lysosome fusion; (5) particles are degraded or digested inside the 
phagolysosome; (6) pharmaceutical ingredients or nutrients are absorbed; (7) indigestible 
materials are excreted.58 By taking advantage of this behavior, intracellular release can be 
achieved. Figure 2 shows the overview of macrophage digestion of a polymer encapsulated 
drug particle.  
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Figure 2. Typical macrophage phagocytic uptake of drugs 
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CHAPTER II 
RELATED WORKS 
 
Chitosan Hydrogels 
Chitosan has a low solubility at neutral or alkaline pH. Because of this, it is difficult 
for chitosan to form hydrogel at different pHs.12 Several research groups have developed 
various chitosan derivatives to improve water solubility, such as N-carboxylethyl chitosan,60 
chitosonic acid,61 an glycidyl methacrylate chitosan.62,63 Other  chitosan derivatives such as 
chitosan-poly (glycidyl methacrylate) have been reported to immobilize biomolecules with 
pH and thermal stability64.  
One highly efficient derivative can be synthesized through a methacrylamide reaction 
by attaching methacrylate to the chitosan amine group.65 With the carbon-carbon double 
bond on the methacrylate group present, further modification or gelation can be 
performed.65,66 Methacrylated chitosan hydrogel dressings saturated with oxygen has 
successfully enhanced the wound healing process with enhanced collagen synthesis and 
epithelial growth through improved oxygenation.67,68 Other studies have reported that 
peptides and growth factors can be attached to methacrylated chitosan and increase cell 
adhesion.65,66  
Chitosan hydrogels have been widely used in tissue regeneration. Chitosan hydrogels 
with sustained release of FGF-2 have been shown to enhance wound healing.69–71 However, 
very few studies have combined wound dressing with pH sensitive hydrogel. By taking the 
advantage of chitosan’s cationic nature and the pH changes that occur during the wound 
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healing, chitosan wound dressings can release drug specifically during the inflammation 
stage to prevent chronic inflammation.  
PEG Diblock/Triblock Copolymer 
One family of PEG block polymers that can self-assemble and form micellular or 
liposomal structures is 1,2-distearoyl-sn-glycero-3-phosphoethanolamine (DSPE) – PEG 
block copolymer.46 Although DSPE-PEG can form sterically stable liposomes, it is typically 
combined with other polymers to form multicomponent-micelles.11,72,73 In one study, a mixed 
poly(histidine)-PEG block polymer and DSPE-PEG block polymer micelle system was 
developed.11 The resultant micelle system exhibited pH sensitivity from pH 5 to 7.4. Drug 
release was increased at lower pH, which was shown through micelle swelling and ionization 
by size distribution and zeta potential, respectively. Cell culture using 4T1 murine breast 
cancer cells also indicated pH-dependent enhancement of paclitaxel uptake by micelle 
encapsulation. Matthias and co-workers have studied a liposome composed of dipalmitoyl 
phosphatidylcholine, cholesterol, and DSPE-PEG in vivo.72 Compared with direct injection 
of dexamethasone, an anti-inflammatory drug, the PEGylated liposome encapsulated 
dexamethasone showed a significant reduction of the inflammatory response in multiple cell 
types, such as T-cells and B-cells. Other systems, such as a hydrogenated egg 
phosphatidylcholine, cholesterol, and DSPE-PEG mixture has been used to study the 
sustained circulation clearance effect of PEGylated particle.73 The result indicated that 
PEGylated particles could extend circulation time in rats by reducing mononuclear phagocyte 
cell recognition; however, this effect was inhibited by IgM secretion from B cells after the 
first PEGylated particle injection.73,74 
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Another common combination is with PLGA, which is also a biodegradable and 
biocompatible polymer.75 The behavior of PLGA-PEG is partially dependent on the 
molecular weight ratio between PLGA and PEG.54 It was reported that PLGA-PEG 
nanoparticle with PEG molecular weight of 5000 has a higher degradation rate and lower 
sustained drug release in vitro when the weight percentage of PLGA is decreased.54 
Moreover, PEG-PLGA diblock copolymers and PEG-PLGA-PEG triblock copolymers have 
been reported to exhibit gelation behavior.76,77 Low molecular weight PEG-PLGA-PEG 
triblock polymers, with PEG and PLGA molecular weights of 550 and 2810 respectively, 
were shown to form a hydrogel at physiological temperature while existing as a fluid at room 
temperature thus having the potential to be an injectable hydrogel implant. Drug release 
behavior with the hydrophobic drug ketoprofen resulted in more than two weeks of sustained 
release with first order kinetics.77 Alexandra and co-workers developed implantable devices 
containing indomethacin with a PLGA-PEG coating. With the presence of PEG, the adhesion 
of blood cells onto the implant surface was inhibited and the drug release was sustained for 
three weeks51. Some other PEGylated polymers for drug delivery include PEG and poly(N- 
isopropylacrylamide) star copolymers which can form hydrogel at physiological 
temperatures, similar to the PLGA-PEG system76.  
Poly(ɛ-caprolactone)-PEG-Poly(ɛ-caprolactone ) (PCL-PEG-PCL) triblock 
copolymer was first synthesized by Ge’s group78 and was shown to have low a CMC and 
could encapsulate hydrophobic drug . The micelle was found to have around 5 wt% loading 
capability with nimodipine. Release of nimodipine from the PCL-PEG-PCL micelle could be 
extended to 6-8 days. A study done by the same group using PCL-PEG-polylactide micelle 
displayed similar results with a higher loading capability but shorter releasing time.55 
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Despite of spherical micelle structure, polymer particles can also assemble into other 
structures. polymethacrylate-PEG copolymer synthesized by Cheng  has been reported to 
form multiple structures such as spherical micelles, cylindrical micelles, super-helices, and 
super-rings in a concentration dependent manner.79 
However, most of these ‘traditional’ diblock or triblock copolymers are highly 
dependent on the component properties and the only modifiable parameter is molecular 
weight of each component. Other methods for particle optimization were limited into end 
group reactions or using a copolymer mixture. 
PEG-D5HIP Polymer 
Several efficient alternating block copolymer preparation methods have been 
developed. Condensation polymerization between PEG and dimethyl-5-hydroxyisophthalate 
(D5HIP) was developed by Kumar et al.80. This reaction system acts under mild conditions 
and requires no organic solvent. The resulting product, poly[(poly- (oxyethylene)-oxy-5-
hydroxyisophthaloyl] (Ppeg), is an amphiphilic polymer80. By attaching different modifiers 
on to the hydroxyl on phenyl ring, various properties can be achieved. Modification of the 
hydrophobic chain can impart self-assembly capabilities on the polymer (Fig. 3).  
Further modification of the polymer using different PEG molecular weight of 600, 
900, and 1500 (Ppeg-600/900/1500) have been produced with isolated yield reached around 
80%.80 Modification of Ppeg-600 with decanoyl chloride and bromodecane attaching to 
hydroxyl group has also been examined. To measure the interaction of the polymer with 
cations, calcium ions were incubated with the polymer and UV adsorption spectra of the 
polymers with different modifications was generated. Compared with unmodified Ppeg-600, 
the alkyl and esters modifications showed significantly lower interaction with calcium ions.81 
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Figure 3. Ppeg-alkanes form micelles in aqueous solutions. The hydrophilic shell is 
composed of PEG chains and the hydrophobic core results from the alkyl chains and 
aromatic rings. 
Ppeg-600 has been modified with bromodecane, 12-bromododecanol, and 11-
bromoundecanoic acid to evaluate the polymer’s drug delivery capabilities82. The micelle 
size and CMC were modification-dependent. The overall efficiency of aspirin encapsulation 
was found to be near 80% and 7% for naproxen when loading at a 1:5 drug: polymer ratio. 
Animal studies exposing the drug loaded micelles to the inner surface of the rats’ inflamed 
ear and measuring the auricular thickness showed enhanced therapeutic effects82.  
However, sustained release has not yet been studied and the effect of side chain 
length and function groups on polymer micelle behavior remains unclear. Furthermore, 
because only Ppeg 600 was used in the study, the difference caused by PEG molecular 
weight is unknown. 
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CHAPTER III 
THE IMPACT OF BIOMATERIALS ON MACROPHAGE POLARIZATION 
 
Abstract 
Herein, we give a brief overview on how changes in macrophages and fibroblasts 
phenotypes are critical biomarkers for identification of implant acceptance, wound healing 
effectiveness, and are also essential for evaluating the regenerative capabilities of some 
hybrid strategies that involve the combination of natural and synthetic materials. The 
different types of cells present during the host response have been extensively studied for 
evaluating the reaction to different materials and there are varied material approaches 
towards fabrication of biocompatible substrates. Several fabrication strategies are discussed 
to control the phenotype of infiltrating macrophages and fibroblasts. It is essential to factor 
all the different design principles and material fabrication criteria for evaluating the choice of 
implant materials or regenerative therapeutic strategies.  
Introduction 
The field of biomaterials is an evolving interface between the synergistic topics of 
science and engineering. There is clearly a growing need for technologies that can provide 
treatment, while promoting regeneration of healthy parenchymal and stromal tissue.83 
However, the innate and complex intricacies in biological responses to material properties 
are challenging to predict a priori, meaning that implant failure often occurs as a result of 
inflammation84 and fibrous encapsulation.85 Abating or eliminating such host responses is of 
central importance in current bio-implant design. There are several key characteristics 
involved in the host response to biomaterials, two of which are activation of macrophages 
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and fibroblasts.86 These cells are essential to tissue regeneration, with the former mediating 
inflammation and the latter instigating fibrous encapsulation. 
Macrophages are thought to exist on a spectrum of phenotypes bookended by 
classically activated M1 macrophages and alternatively activated M2 macrophages.87,88 
Another description of macrophage activation uses an analogy of a color wheel, in which 
classically activated, wound-healing, and regulatory macrophages occupy the ‘primary 
colors’ that blend into ‘shades’ of macrophage activation.89 M1 macrophages can be 
activated by lipopolysaccharides (LPS) or interferon-γ (IFN-γ) and produce cytokines and 
chemokines such as tumor necrosis factor-α (TNF-α), interleukin-1 (IL-1), IL-6, and nitric 
oxide; while M2 macrophages can be induced by IL-4 and release cytokines including 
transforming growth factor-β (TGF-β) and IL-10.57,90–92 M1 macrophages are also known as 
inflammatory macrophages, which aid in ‘sterilizing’ the wound environment after injury, 
such as implantation of a biomaterial; in contrast, M2 macrophages are often termed anti-
inflammatory and relieve inflammation and aid in tissue formation. These two contrary 
functions allow macrophages to play critical roles in host responses.57 Despite in depth 
studies examining macrophage function in the implant milieu, their response and activation 
pathways are not completely understood. Macrophages function differently depending on 
their location93 and can be further polarized into several sub-phenotypes base on their 
microenvironment.90 
The substrate and chemically sensitive differentiation of fibroblasts into 
myofibroblasts have dramatic influence on the reorganization of the extracellular matrix 
(ECM).94 Myofibroblasts have been studied for their role in tumor stromal remodeling and 
their influence on modifications of the ECM. Their presence is mediated by two main 
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factors: de novo stress due to contractile actin bundles being activated and through 
mechanical stress.95 Both of these factors are also inherently linked to macrophage 
polarization towards acute or chronic responses. Contractile actin bundle mediated change in 
ECM activity has been observed to be responsible for the secretion of TGF-β or its latent 
form (L-TGF-β), which also results in classical activation of the macrophage response.96 
Similarly, the mechanical stress has been known to play a role in the activation of matrix 
metalloproteinases (MMPs), which are responsible for cleaving TGF-β from its latent form. 
Both fibroblasts and myofibroblasts secrete collagen and exert mechanical influence to alter 
ECM organization as a function of the material properties of implants or wounds (Fig. 4).    
 
Figure 4. Macrophage and fibroblast activation and interaction responding to biomaterial 
implant. The cell response is dependent on implant material, surface patterns, and cytokines 
released from implant.    
It is known that shortly after implantation, protein adsorption at the implant surface 
will take place in seconds, followed by neutrophils adhesion which last 1 or 2 days.97 
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Generally monocytes will be recruited to the site of injury and will differentiate into 
macrophages within one week after implantation. In most situations, macrophages will first 
be polarized into M1 macrophages for pathogen clearance and lead to acute inflammation, 
which lasts from minutes to days. M2 macrophages usually appear shortly after inflammation 
begins to subside.97 On the other hand, fibroblasts appear from minimal levels to the implant 
site by about 3 days. Their population decreases around one week following injury where 
they are active and polarized into myofibroblasts, which will present and stay activated for 1-
2 weeks before their presence is abated and the fibroblast population increases.95,96 The 
fibroblast population will rise to optimal levels after that and remain plateaued.97 If the 
material is not able to be phagocytosed, macrophage presence will persist, and eventually 
culminates in macrophage fusion into multinucleate giant cells followed by fibrous 
encapsulation of the foreign body.98 The time line of macrophage and fibroblast presentation, 
along with their phenotypes, after implantation is shown in figure 5.  
 
Figure 5. Time line of macrophage, fibroblast, and myofibroblast population at the implant 
site. 
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Inflammation and formation of the fibrotic capsule were two of the first markers of 
the host response observed.99,100 Eventually it became essential to define the fibrotic response 
as beneficial or inhibitory. Depending on the location of the implants, surface properties, 
material types, and time-scales over which the studies were conducted, the extent of the host 
response was found to vary greatly.  
Herein, we describe macrophage and fibroblast responses to bio implants with various 
materials, structures, and implant locations. The purpose of this review is to organize the 
current efforts in modulating macrophage and fibroblast response to reduce the foreign body 
response (FBR) caused by bioimplants and analyze how material selection and implant 
geometry can alter the host response. This review provides design principles for 
biocompatible implant intended for disparate locations.  
Influence of Material Selection on the Host Response 
Material selection is one of the primary factors for consideration in designing 
biomedical implants. Here, we have classified biomaterials into three main types: natural, 
synthetic, and hybrid materials. Natural materials derive from living sources and are 
generally biocompatible. Synthetic materials have potentially infinite diversity and are 
generally more amenable to sterilization and fabrication processes than their naturally 
derived counterparts.101 Hybrid materials aim to combine the advantages of both natural 
materials and synthetic materials through physical and/or chemical linkages of the two types 
of materials. This section will discuss how to modulate the host response following 
implantation from the materials choice aspect.  
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Natural materials 
 Natural materials can range the gamut from bioactive or bio-inert. Some 
materials can significantly modulate cell phenotypes and alter the host response such that 
inflammatory environments are modulated into ant-inflammatory ones.102 Conversely, other 
materials are ‘invisible’ to the immune system and have low protein and cell adsorption, 
some of which can even inhibit monocytes differentiation.103,104     
However, natural materials often exhibit responses that vary depending on the micro-
environment in which they reside.105 Improper usage of natural materials can also lead to an 
enhanced FBR. Owing to the variability of molecular weight and confirmation during natural 
synthesis, the same natural material can induce a variety of host responses, particularly in 
regards to macrophage and fibroblast phenotype. Appropriate application of natural materials 
is essential for reducing the host response. The following sections will analyze different 
cellular response principles for alginate, chitosan, and hyaluronic acid.  
Alginate 
Alginate is a polysaccharide derived from algae and has been widely used for drug 
encapsulation and tissue engineering owing to its low toxicity, good biocompatibility, and 
gelation under mild conditions with divalent cations. In addition, the structure of alginate is 
similar to the ECM of living tissues and provides a moist, inert microenvironment for 
encapsulated cells.  
Alginate is generally considered to elicit an anti-inflammatory response. High 
molecular weight alginate (500 kDa) has been shown to reduce pro-inflammatory cytokines 
IL-1β and IL-6.106 However, a recent study showed that cellular responses can be modified 
through changing the ratio of guluronic acid (G block) to mannuronic acid (M block). 
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Alginate containing 94% M block leads to higher TNF-α secretion than for LPS stimulated 
RAW264.7 macrophages while polymannuronate (100% M block) of a similar molecular 
weight produces significantly less TNF-α.107 Further research demonstrated that this effect 
was more pronounced when comparing alginate degradation products from the G block and 
M block.108,109 Alginate oligosaccharides, particularly unsaturated guluronate oligosaccharide 
prepared by enzymatic degradation (GOS-ED), induced strong inflammatory responses and 
led to M1 polarization, measured by nitrite production, in RAW264.7 cells with a 
concentration and molecular weight dependence.109 However, alginate oligosaccharides 
degraded either by acid hydrolysis or oxidation showed no significant effect on naïve 
RAW264.7 cells, and oxidative degraded G block (GOS-OD) can even reduce the 
inflammatory response in LPS stimulated RAW264.7 macrophages in a concentration 
dependent manner.108 Pathway studies found that GOS-OD can efficiently inhibit LPS 
binding to the cell surface and reduce M1 macrophage activation.108 Currently, although very 
few researchers have studied the effects of alginate degradation products on fibroblasts, it 
was shown that NIH/3T3 fibroblasts can accelerate the degradation rate of calcium-alginate 
hydrogels in vitro compared to an acellular sample.110 In vivo interactions between 
macrophages and fibroblasts may further increase hydrogel degradation rates and enhance 
host responses.  
The material properties of alginate are also highly affected by the G/M ratio. One 
obvious difference that arises from altering the G/M ratio is the mechanical properties of the 
resulting gel. The G block forms an ‘egg box’ structure in the presence of di- and tri-valent 
cations, resulting in improved crosslinking and higher stiffness compared to M block rich 
alginate hydrogels.111 Alginate-polylysine with different G/M ratios implanted in the 
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peritoneal cavity in Albino Oxford rats only showed slight differences in cell overgrowth. 
Increased macrophage presence and fewer fibroblasts were observed on alginate with lower 
G/M ratios at 5 days after implantation; however, this difference quickly disappeared after 7 
days. There are a limited number of studies interrogating the relationship between the host 
response and the G/M ratio of alginate. Many of the studies that have been performed have 
inconsistent results.112–115 A variety of properties, such as molecular weight, and molecular 
configuration could explain these discrepancies. The alginate with a lower G/M ratio resulted 
in higher cytokine release.114 However, other studies have shown that alginate with 60% M 
block can induce higher amounts of TNF-α than 75% M block alginate, and 
polymannuronate did not have a significant difference in TNF-α production compared with 
the control group.107 There is a clear need to better understand how the G/M ratio influences 
macrophage phenotypes and alters host responses.  
Unlike macrophages, fibroblasts appear to be influenced by mechanical properties 
and drug or cytokine loading rather than alginate alone. Human fibroblasts cultured on an 
alginate sponge showed the same viability compared to the control106 while alginate hydrogel 
loaded with basic fibroblast growth factor (bFGF) significantly enhanced fibroblast 
proliferation.116 Faster cell infiltration and vessel formation were observed in the bFGF 
loaded hydrogel when implanted in rats subcutaneously.116 Vegas et al. 117 further 
demonstrated that chemical modifications to alginate can significantly alter fibroblast 
responses. A systematic library was established along with polymer mixtures to form barium 
alginate microcapsules. In rodent models, the extent of fibrosis was found to be mouse strain 
dependent. Fibrotic responses to these modified alginate implants were subsequently studied 
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in non-human primate models and triazole containing combinations were identified as anti-
fibrotic materials.117  
Chitosan 
Another natural material whose properties and host responses are impacted by the 
ratio of its monomers and its molecular weight is chitosan. Chitosan is partially deacetylated 
chitin (poly-N-acetylglucosamine), which is the main component of crustacean shells. 
Chitosan is biodegradable with a degree of deacetylation (DD) ranging from 15% to 85%118 
and insoluble in human bodily fluid at high molecular weights (MW > 20 kDa).119 
Chitosan is generally known to induce a higher inflammatory response than glass 
slides and tissue culture plastic in vitro.120–122 Higher cell mobility was observed for human 
primary monocyte derived macrophages cultured on chitosan films compared to tissue 
culture polystyrene.121 Other studies have shown increased M1 markers such as IL-6, TNF-α, 
and IL-1β in the first three days while M2 cytokines IL-10, IL-12, and TGF-β increased 
significantly after 10 days.120 Mechanistic studies have shown that macrophages recognize 
chitosan via CD20, which is an M2 macrophage marker.120 On the other hand, fibroblast 
viability can be increased by chitosan. Human gingival fibroblast proliferation was enhanced 
when cultured with chitosan microparticles through ERK1/2 (extracellular-signal-regulated 
kinases) pathway activation. Growth factors such as PDGF (platelet derived growth factor) 
loaded chitosan can further increase cell proliferation.123 In addition, chitosan was reported to 
favor wound healing; however, no significant difference was found in ECM production of 
L929 mouse fibroblasts with or without chitosan.124 This result suggests that chitosan did not 
directly affect fibroblasts, but stimulated secretion of cytokines such as TGF-β and PDGF 
from macrophages. 
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Chitosans with different DDs are known to alter host response and higher DDs are 
known to provoke an antimicrobial response.125,126 Further studies have shown that high 
molecular weight chitosan scaffolds (MW ~ 830-890 kDa) with 95% DD significantly 
reduced cellular adhesion and have a lower M1/M2 ratio, measured by CD206 (cluster of 
differentiation 206) for M2 macrophages and CCR7 (C-C chemokine receptor type 7) for M1 
macrophages, compared to chitosan scaffolds with 85% DD.127 Further reducing the DD of 
high molecular weight chitosan (76% DD) resulted in high secretion of the inflammatory 
cytokine IL-1β in bone marrow derived mouse macrophages in vitro, while chitin (7% DD) 
was a less potent stimulator of the M1 response.128 Other studies with fibroblasts showed 
chitosan (MW ~ 200-260 kDa) with 89% DD largely increased the human dermal fibroblasts 
population in vitro compared to 58% DD.129 In contrast, reduced migratory activity of 3T6 
fibroblasts was found in both chitin (MW 300 kDa, DD < 10%) and chitosan (MW 80 kDa, 
DD > 80%).130 Taken together, although there are lab to lab differences such as chitosan 
purity, MW, and morphology, these responses suggest there might be a non-linear 
relationship between cellular responses and DD.  
Mechanistic studies have also been performed to ascertain the effect of acylation on 
the inflammasome, with multiple pathways implicated. IL-1β released in the presence of 76% 
DD chitosan was inhibited in both peritoneal and bone marrow derived macrophages 
harvested from NLRP3-/- mice compared with wild type (WT) mice. Pathways including K+ 
efflux, reactive oxygen species generation, and lysosomal destabilization were also involved. 
All of these pathways are necessary for peak IL-1β release in response to chitosan.128 
Pathways also varied depending on the initial macrophage phenotype. In M0 and M2a 
macrophages, interleukin-1 receptor antagonist (IL-1Ra) could be induced by 80% DD 
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chitosan but not 98% DD chitosan without activating the IL-4 to signal transducer and 
activator of transcription-6 (IL-4/STAT-6) axis, while there was no significant difference for 
M1 macrophages.118 Moreover, 80% DD chitosan at both medium and low molecular weight 
was reported to cause delayed STAT-1 activation, while 98% DD chitosan did not induce a 
delayed response.118 
Although the mechanisms of macrophage activation as a result of chitosan acylation 
have been widely studied, the results are not directly comparable owing to the use of 
different macrophage cell lines, different molecular weights, and sources of chitosan. Other 
difficulties in comparing chitosan activation of macrophages stem from limited studies 
comparing a variety of DDs. Some studies have even compared the acylation effect on 
macrophages using chitosan with molecular weights that differ by orders of magnitude,125 
which may lead to a less reliable conclusion since the molecular weight of chitosan might 
also impact cellular responses and modulate the host response. Since the inflammatory 
response is not linearly related to DD,127,128 there is a need for systematic studies over a range 
of DDs using consistent molecular weights. The effect of chitosan on different macrophage 
polarizations is also necessary to provide a clearer picture on how implanted chitosan would 
modulate the host response. 
Chitosan with molecular weights ranging from 50 to 300 kDa does not have a 
significant effect on macrophage response.131 Similar to alginate, very low molecular weight 
chitosan, specifically degradation products termed chitosan oligosaccharide (COS), have 
been reported to induce a strong inflammatory response.132,133 Chitosan enzymatically 
hydrolyzed with a degree of polymerization of 3-6 was found to greatly enhance 
inflammatory responses by increasing TNF-α and NO production in RAW 264.7 
26 
 
macrophages. COS induced inflammation is mainly caused by activating toll like receptor-4 
(TLR-4).132 Interestingly, 20 kDa chitosan has little to no effect on macrophage morphology 
and CD40 expression while COS with an average molecular weight of 750 Da causes M1 
activation.133 Although studies in fibroblasts showed no significant effect of COS (MW ~ 
2.5-10 kDa) in L929 fibroblasts in vitro,134,135 intercellular interactions in vivo could alter 
fibroblasts responses. Even though high molecular weight chitosan does not induce a strong 
inflammatory response, degradation of the implant may result in an undesirable M1 
macrophage response at these later time points. Chitosan (80%DD) with molecular weights 
of 10, 40, and 150 kDa were implanted into skeletally aged rabbit knee trochlea. The low 
molecular weight materials have a faster degradation rate compared to the 150 kDa 
polymer.136 High degradation rates can lead to massive release of COS and further cause 
serious implant inflammation; conversely, low degradation rates may affect tissue infiltration 
into the implant. 
Fibroblast responses to chitosan are heavily influenced by chemical modification and 
mechanical properties. Chitosan hydrogels with larger pore sizes and higher porosity cultured 
with GM3348 human skin fibroblasts resulted in proliferation and infiltration.137 The study 
also suggested that fibroblast migration and proliferation are positively related to the swelling 
ratio. Detailed studies are listed in the next section.  
Loading chitosan with drugs or chemokines can also modulate cellular responses. 
Chitosan nanoparticles loaded with the non-steroidal anti-inflammatory drug (NSAID) 
diclofenac reduces IL-6 and prostoglandin E2 (PGE2) secretion from LPS activated human 
macrophages while increasing TNF-α release.138 In contrast, chitosan encapsulating the 
anticancer agent methylglyoxal leads to high inflammatory mRNA expression of IL-6, IL-1β, 
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TLR-4, and TNF-α in sarcoma-180 tumor bearing mice139. It has been reported that 
maleimide-streptavidin modified methacrylamide chitosan hydrogels can be loaded with 
growth factors such as IFN-γ and remain at high concentration in chitosan scaffolds with less 
than 20% release after one month in vitro. However, when these materials were implanted 
into female Fischer 344 inbred adult rats, they did not show observable differences compared 
to chitosan implants without the growth factor.140  
Hyaluronic acid 
Native hyaluronic acid (HA) is a non-sulfated glycosaminoglycan (GAG) with 
molecular weights up to 107 Da.141 HA can be naturally degraded and re-synthesized in 
vivo142 through different cells including macrophages and fibroblasts, and is known to 
interact with several cell surface markers, such as CD44.143  
One of the characteristics of HA is that it can influence the host response in a 
molecular weight dependent manner; high molecular weight HA often leads to anti-
inflammation144 and low molecular weight HA can cause inflammation.145 Recently, HA 
molecular weight effects on macrophage reprogramming and cytokine release have been 
demonstrated.146 HA molecular weights spanning 10-1 to 103 kDa were tested in macrophages 
polarized with LPS/IFN-γ or IL-4 along with naïve cells. Very high (103 kDa) and very low 
molecular weight (10-1 kDa) HA have direct influences on macrophage polarization 
regardless of the initial phenotype.146 In different phenotypes, most anti-inflammatory 
cytokines increase logarithmically with molecular weight; in contrast, most pro-inflammatory 
decrease logarithmically (Fig. 6).146 Similar studies were performed on LPS/IFN-γ activated 
human peripheral blood monocytes obtained from donors. IL-1β production after incubation 
with 5 to 1,700 kDa HA showed a decrease with molecular weight without a clearly 
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identifiable trend. Large variety between each donor was found, and was used to explain the 
lack of a trend.141 High MW HA was also shown to enhance fibroblast proliferation in 
gingiva147 but decrease scar collagen production in the dermis.148 Taken together, high MW 
HA can increase tissue regeneration and reduce fibrous encapsulation. 
 
Figure 6. Gene expression of macrophages in response to hyaluronic acid with different 
molecular weight. Naïve or pre-activated macrophages were treated with HAs for 24 h before 
phenotypic assessment was made. Adapted with permission. Copyright 2015 American 
Chemical Society 
Although numerous studies on cellular responses to HA have been conducted in vitro, 
there is uncertainty on the effect of HA molecular weight in vivo. One interesting 
phenomenon found both in vivo and in vitro studies showed that LPS activated macrophages 
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could increase HA synthase (HAS) 1 and HAS 2 mRNA expression and decrease 
hyaluronidases.149 Despite the reduction in hyaluronidases from M1 macrophages, rapid 
degradation of HA was still observed in macrophages from the lungs of LPS treated mice 
even though the HA concentration increased in other tissues.149 Since lung fibroblasts are 
known to produce hyaluronidase upon INF-γ and TNF-α simulation,150 which are both 
associated with M1 macrophages, the result provided strong evidence for macrophage-
fibroblast interactions in response to HA in an inflammatory environment. In addition, HA 
synthase is able to synthesize high molecular weight HA,143 thus upregulation of synthase 
will lead to high molecular weight HA and reduce the inflammatory response caused by HA. 
The rapid degradation of HA in macrophages may abrogate this effect since low molecular 
weight HA is pro-inflammatory. The main surface marker on macrophages that recognizes 
HA is CD44, which is upregulated in inflammatory environments.146 Although IL-4 and 
LPS/IFN-γ activated macrophage have similar levels of CD44 expression, IL-4 induced M2 
macrophages can cause CD44 sulfation by post-translational modifications such as increasing 
chondroitin sulfate, while TNF-α can significantly reduce the sulfation and HA binding to 
macrophages.151 Since inhibition of chondroitin sulfate adhesion on CD44 could increase HA 
binding, chondroitin sulfate also regulates HA binding.151 Considering these factors, HA with 
pre-sulfation treatment may also reduce macrophage adhesion and induce an anti-
inflammatory response. In fact, collagen films coated with 16% sulfated hyaluronic acid 
cultured with macrophages in vitro leads to increased M2 cytokines such as IL-10 and lower 
M1 cytokines such as TNF-α and IL-12 compared to 6% sulfated HA followed by native 
HA.152,153 Such an effect was also found in fibroblasts. Human dermal fibroblasts cultured 
with artificial ECM containing sulfated HA had increased cell adhesion with increased 
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sulfation without effecting myofibroblast differentiation.154 Reduced MMP-1 levels were also 
observed in fibroblasts when cultured with highly sulfated HA.154 All these studies suggest a 
tissue regeneration effect of highly sulfated HA. 
Synthetic materials 
Compared to natural materials, synthetic materials are generally less biocompatible. 
However, due to their high plasticity, synthetic materials can easily be fabricated to have 
tunable mechanical properties, controlled degradation rates, and various structures.155,156 
Unlike natural materials, many synthetic materials are more resistant to increased 
temperature and can be processed or sterilized easily. Synthetic materials are generally 
divided into bio-degradable and non-biodegradable categories. 
Biodegradable synthetic materials 
Polymers such as poly(lactic acid) (PLA), poly(lactic-co-glycolic acid) (PLGA), and 
poly(glycerol sebacate) (PGS) are commonly used biodegradable materials. An ideal 
biodegradable implant can maintain their function and degrade without releasing cytotoxic 
substances. One of the major advantages of using biodegradable implants is that a second 
surgical intervention is not required.101 With controlled degradation kinetics, tissue 
regeneration rates ideally match the degradation process. The degradation mechanism and 
rate is determined by material choice and fabrication. Since tissue regeneration rates vary for 
different organs, material selection is also dependent on implant location, as will be 
discussed later.  
Degradation behavior is largely dependent on material selection. Elastic and 
mechanically stable PGS with tunable degradation rates have been used in soft tissue 
engineering.157 PGS has been reported to have an in vivo half-life of 21 days and is 
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particularly useful in vessel and neural regeneration.158 PGS vascular grafts implanted in rat 
abdominal aortas for 1 year were completely degraded and were functionally similar to 
native rat aortas.159 For neural reconstruction, PGS bars were implanted underneath the 
sciatic nerve in Fisher rats. Complete degradation was observed 60 days after implantation 
with no apparent difference in macrophage population or fibrotic thickness compared to the 
sham surgery group.157 Other materials such as PLA have a low in vivo degradation rate 
ranging from months to years and have been used in clinical application.160 Because PLA 
alone often induces a relatively high inflammatory response in the early stage of 
implantation,161–163 PLA copolymers or surface coated PLA have been synthesized to 
improve host responses. Cardiovascular stents composed of high molecular weight PLA 
blended with phospholipid polymer bearing phosphorylcholine groups were able to reduce 
thrombus formation and significantly decrease inflammatory cytokines IL-6, IL-1β, and 
TNF-α release compared with PLA alone when implanted subcutaneously in rats and in 
arteries of rats or rabbits.162 Unlike most natural materials, which cannot be processed under 
harsh reaction conditions, PLA implants can be fabricated through various processes 
including hot-melt extrusion,160 solvent evaporation,164 and organic solvent dissolving,164 due 
to its thermal and chemical stability. 
There are also several disadvantages to synthetic materials, as these materials are 
known to induce an acute inflammation upon implantation. Currently the most popular 
solution is to coat the implant with an anti-inflammatory drug. PLGA scaffolds with vanillin 
coating significantly increased NIH/3T3 fibroblast proliferation. Increased ECM production 
and reduced reactive oxygen species (ROS) were also observed in vivo using Wister rats.165  
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The other disadvantage is that, especially for biodegradable synthetic materials, in 
many cases, degradation products are not biocompatible and will lead to an inflammatory 
response. Secondary acute inflammation is often observed in the site of implantation during 
the rapid degradation period.161 Thus, designing a bio-implant that can stay functional as long 
as the therapy requires and then degrade at a controlled rate that will not lead to a strong 
inflammatory response becomes an issue. One commonly used method to reduce implant 
host response is combining implant with anti-inflammatory drug such as 
dexamethasone.160,166 Biodegradable materials can achieve diffusion and degradation 
mediated controlled release. Both PLA and PLGA based polymers have sustained drug 
release kinetics.160,166 An effective solution recently developed is, rather than avoiding 
release of harmful degradation products, combining a secondary material with the degradable 
implant that can neutralize the degradation products. Materials with buffer capabilities such 
as apatitic nanoparticles can significantly reduce the acidic environment in the implant site 
caused by PLA or PLGA degradation products.167 Reduced degradation rates and host 
responses, including macrophage infiltration and fibrous encapsulation have been reported.167  
Degradation products can also be active pharmaceutical ingredients.168–171 Calcium 
phosphate cement (CPC) implants containing PLGA microparticles have been developed 
recently as bone implants.168 It was hypothesized that the acidic degradation product of 
PLGA could be neutralized by calcium phosphate, which would eliminate the inflammatory 
response caused by PLGA degradation while further releasing calcium and phosphate ions 
that favor bone regeneration.168 Although the degree of neutralization and the amount of ion 
released was not tested, the implantation outcome in femoral condyle of rabbits showed 
enhanced bone formation without inflammation in CPC with PLGA compared to CPC alone 
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or CPC with other non-degradable microparticles.168 CPC has also been coupled to PLGA 
through end group modified PLGA.169 Here, acid terminated PLGA showed higher 
degradation and bone formation compared to end-capped PLGA.169 In addition, the 
degradation rate of CPC-PLGA was only slightly affected by PLGA molecular weight and 
microparticles size but was highly dependent on PLGA end group and particle 
morphology.170,171 With appropriate end group modification to control degradation rate, 
CPC-PLGA implants could be applied to various situations. Antacid magnesium hydroxide 
was found to stabilize PLGA encapsulated proteins,172 such as bFGF,173 using a similar 
strategy. By combining different materials that can neutralize degradation products, these 
studies provide a novel method to reduce degradation induced inflammation and even 
enhance tissue regeneration.   
Non-biodegradable synthetic materials 
Non-biodegradable materials are often used as permanent implants. Compared to 
biodegradable materials, non-biodegradable materials are more chemically stable and can 
avoid cytotoxic and inflammatory responses caused by degradation products. However, low 
cell infiltration can lead to the formation of a fibrous capsule and may require a second 
surgery if removal is desired.   
Titanium is the most commonly used permanent bone implant. Applications include 
dental implants and total joint arthroplasty. Although it has been reported that titanium 
alloys, compared to zirconium alloys, lead to a higher inflammatory response through 
increased IL-6 and TNF-α release from osteoblasts and fibroblasts,174 titanium is generally 
the first choice for bone implants due to its mechanical properties and chemical resistance. 
Several methods have been developed to reduce the inflammation caused by titanium 
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implants such as modifying the surface chemistry175,176 and surface patterning.177 Hydrophilic 
surface modified titanium can significantly decrease gene expression of inflammatory 
cytokines TNF-α, IL-1, and IL-1β in THP-1 and RAW264.7 macrophages.175,176 Surface 
modifications with calcium or strontium ions also induce more anti-inflammatory M2 
J774.A1 macrophages.178 Other bone implants such as poly(vinyl alcohol) (PVA), with more 
mechanical tunability than titanium, have also been developed.179 PVA caused little to no 
inflammation in a rabbit knee joint implant model, but resulted in fibrous encapsulation 3 
months after implantation. Decreasing fibrosis is one of the major challenges in non-
degradable implants.     
Non-biodegradable polymers are often used for or with surface modification of 
biodegradable or natural materials to change their chemical and physical properties. 
Poly(ethylene glycol) (PEG) is often conjugated to implants or particle surfaces to increase 
their wettability or water solubility.52 PEG also has a ‘stealth’ capability46 as it can avoid cell 
recognition and reduces protein and cell adhesion.180 Poly(propylene) (PP) is more generally 
used as a mesh implant for hernia repair in clinical medicine. It was reported to activate both 
inflammatory IL-6 and anti-inflammatory IL-1Ra92 and caused chronic inflammation with 
fibrous capsule formation.98,181 Host responses that include macrophage and fibroblast 
overgrowth, fibrosis, and foreign body giant cells (FBGCs) could be largely decreased by 
coating with a polyurethane based hydrogel as shown by dermal implantation in rats.182 
Loading TGF-β1 onto PP mesh surface could also increase fibroblast proliferation in a dose 
dependent manner.183 PP mesh morphology also effects host response. Multifilament meshes 
can lead to stronger inflammation both acutely and chronically compared to monofilament 
meshes.184  
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Despite the improved mechanical properties of non-degradable biopolymers, 
biodegradable materials are often favored since they do not require a secondary surgery and 
favor tissue regeneration. In addition, for permanent implant applications, it is important to 
note that non-biodegradable implants are susceptible to wear. Implant abrasion is one of the 
reasons for permanent implant failure, which is often found in joint replacements. Wear 
mediated particles can lead to inflammation,185 which can further cause perennial 
overexpression of TNF-α and IL-1β.186 Coating these materials with a lubricant could 
possibly reduce the abrasion.  
Hybrid materials 
On the basis of the above studies, a compelling case can be made for the inclusion of 
hybrid materials for implants. Since most natural materials do not have the range of 
mechanical properties that synthetic materials are capable of spanning187 and many synthetic 
materials lead to inflammatory responses, there is increasing interest in developing hybrid 
materials that incorporate the advantages of both natural and synthetic materials to form 
biocompatible and mechanically tunable implants.  
One of the most common hybrid implants is the type in which synthetic scaffolds are 
coated with natural materials to reduce the host response. From its wide range of properties, 
silk fibroin protein, which is extracted from silkworm or spider-silk, is considered a potential 
candidate due to its mechanical resilience.188 Hybrid scaffolds can be created by combining 
electrospun silk fibers with tunable gelatin hydrogels to synthesize musculoskeletal 
implants.188 By doping these scaffolds with nano-doses of hydroxyapatite, bio-mineralization 
was observed which can be further improved to combat bone degradation and resorption due 
to ailments such as arthritis.188 Naïve silicone implants with thin spider silk proteins showed 
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a minimal inflammatory response, reduced fibrosis, and inhibited differentiation of 
monocytes to macrophages.103 The hybrid surfaces abated the transition of fibroblasts to 
myofibroblasts.189 Those positive responses, which were corroborated by experiments 
involving silk fibroin composite hydrogels derived from silkworm, 190,191 and fibroin 
extracted from spider silk,192 indicated that silk-coated hybrid scaffolds were better at 
reducing inflammatory responses as compared to purely natural implants. Through studies on 
silk proteins and their tunable or biocompatible nature192 these hybrid substrates can be used 
as rigorous models for understanding the host response in different locations within the body.  
Other than coating natural materials on synthetic scaffold surfaces for improved 
biocompatibility, the combination of natural and synthetic material was also developed for 
the purpose of morphological modification. As some natural materials are pH sensitive, 
chitosan at pH’s lower than 6 is positive charged. This allows negatively charged material, 
poly(γ-glutamic acid) (PGA),  to form self-assembled multi-layer structures with chitosan 
through electrostatic interactions.193 Such structures allow chitosan to deliver drugs, and 
successfully reprogramed macrophage responses with the loaded drug. Chitosan-PGA loaded 
with diclofenac was reported to decrease PGE2 released from LPS activated human monocyte 
derived macrophages.138 
The combination of synthetic and natural materials certainly increases the materials 
space for biomedical implants, but also results in high lab-to-lab variability. One example is 
alginate-polylysine (PLL) microcapsules. Alginate-PLL microcapsules have been developed 
since 1980.194 However, alginate-PLL microcapsules with different G/M ratios and molecular 
weights were fabricated, leading to results that are difficult to compare.195 Even with similar 
physiochemical properties, alginate-PLL microcapsules could lead to various inflammatory 
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responses due to differences in the G/M ratio.195 This effect was magnified in vivo as the zeta 
potential increases significantly for alginate-PLL particles with 53% G-block but remains 
unchanged for 43% G-block after 1 day implantation.195 Silk fibroin coated titanium particles 
were also reported to function differently depending on the biological source of the silk.190 
Conclusions and Perspectives 
Both natural and synthetic materials exhibit distinct properties, in which natural 
materials generally exhibit a lower inflammation response and fibrotic encapsulation while 
synthetic materials have tunable mechanical properties. Current efforts in material selection 
mostly lie in reducing the inflammatory response and fibrotic encapsulation caused by the 
bioimplant. One overarching theme is that most cellular responses to materials can be 
modified through molecular weight. Both natural and synthetic materials with small 
molecular weights, particularly degradation products, can lead to inflammatory responses. 
Moreover, host responses to natural materials are further influenced by factors such as 
surface modification and monomer ratio. Currently, most cellular response mechanisms have 
not been completely developed. Detailed host responses to different natural, synthetic, and 
hybrid materials are listed in Appendix A. 
In summary, bioimplant material, modification, and design should be selected based 
on implant location. For biodegradable materials, degradation rates need to match tissue 
regeneration rates in order to avoid implant deformation and fibrous encapsulation. 
Eliminating secondary inflammation caused by degradation products is also an essential 
issue. On the other hand, non-degradable implants, especially for joint replacements, focus 
more on wear resistance and fibrotic encapsulation. In most situations, natural materials can 
reduce acute inflammation upon implantation, but are limited by mechanical properties and 
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most natural materials’ degradation products lead to secondary inflammation. In contrast, 
synthetic materials have high plasticity but are likely to cause acute or chronic inflammation 
after implantation. The host response mechanisms to most materials have not been fully 
elucidated at this point.   
On reviewing the research conducted on the role played by both these cell types, there 
is a need for concurrent studies in order to better understand the host response and evaluate 
the factors that polarize cells. Over the course of the next decade, novel methods may 
improve in terms of spatial and temporal resolution such that real-time observations of 
macrophages, fibroblasts, and myofibroblasts become more commonplace.  
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CHAPTER IV 
PH SENSITIVE METHACRYLATED CHITOSAN HYDROGELS WITH TUNABLE 
PHYSICAL AND CHEMICAL PROPERTIES 
 
Abstract 
The pH of cutaneous wounds is dynamic and correlates with the stage of the wound 
healing process. The inflammation stage is acidic, granulation shifts to a progressively alkali 
pH, and the remodeling phase returns skin to its pre-injury pH. By taking the advantage of 
this pH difference, stage-specific wound treatments can be developed to respond to these 
environmental cues using pH sensitive hydrogels. To obtain tunable physical and chemical 
properties, chitosan was first methacrylated and then crosslinked through three 
polymerization methods: step growth by thiol-ene photoclick reaction, chain growth by UV 
polymerization, and mixed model in which both step growth and chain growth mechanisms 
were used. pH sensitive methacrylated chitosan (MAC) hydrogels were synthesized and 
confirmed through 1H NMR. The resulting hydrogels exhibited adjustable mechanical 
properties, swelling ratios, and pH sensitivities without affecting degradation behavior or in 
vitro cell responses. Cytocompatibility studies were performed using NIH/3T3 fibroblasts. 
Cell proliferation was suppressed when seeded on the hydrogel surfaces compared to tissue 
culture plastic (TCP), yet no measureable cell death was observed. The responsivity of these 
gels to changing pH environments may prove useful as stage-responsive wound dressings.   
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Introduction 
Wound healing can be divided into four stages: hemostasis, inflammation, 
proliferation, and remodeling.1 Generally, hemostasis occurs shortly after injury with 
inflammation following immediately and persisting on the order of days for acute wounds. 
Next, epithelial cells and fibroblasts migrate into the wound site to synthesize collagen and 
regenerate tissues during the proliferation stage.3 During the final stage, remodeling, 
connective tissue is generated and collagen fibers are reconstructed, which determines the 
extent of scarring.1,3 Inappropriate treatment may lead to infection or hematoma formation 
and result in impaired tissue repair and chronic wounds.4 According to Dr. Brian Evans, 
medical director of Advanced Wound Care Center, “chronic wounds affect approximately 
6.7 million people in the United States.”  
Current efforts have mostly focus on cellular behavior such as inflammation and 
infiltration;5,66,70 however, the pH in wound site is dynamic during the healing process and is 
often neglected when designing wound dressings. The surface of normal skin is commonly 
below pH 5, which is essential for pathogen prevention and enzymatic activity.196 Once 
injured, the internal tissue having a pH of 7.4 will be exposed, which provides an 
environment favorable for bacterial multiplication. Cellular products released during the 
inflammation stage of wound healing decrease the pH, which favors antibiotic activity and 
can reduce bacterial colonization.197–199 The shift from the inflammatory stage (pH 5.7 ± 0.5 
standard deviation (SD)) to the proliferative stage (7.6 ± 0.2 SD) results in a gradual pH 
increase.198 This process is illustrated in figure 7. For acute wounds, the healing process 
transitions to the remodeling stage and the pH returns to that of normal skin. In chronic 
wounds, the pH remains alkali.198  
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Figure 7. pH change during wound healing process 
Hydrogels are often used as bioactive wound dressings. Passive wound dressings are 
designed to staunch blood flow and prevent infection.1 Bioactive wound dressings can 
release growth factors, antibacterial agents, corticosteroids, and other drugs designed to aid 
in chronic wound healing.1 By taking advantage of pH changes during wound healing, ‘smart 
wound dressings could be created using pH sensitive hydrogels, which could yield stage-
specific treatment and significantly accelerate wound healing.  
Chitosan is formed by chitin deacetylation and consists of β-(1-4)-linked D-
glucosamine and N-acetyl-D-glucosamine.67 Chitosan is the only naturally occurring cationic 
polymer currently known.15 As a cationic hydrogel, chitosan wound dressing can promote 
binding of negatively charged proteoglycans and glycosaminoglycans, which can further 
promote adsorption of bioactive molecules.200,201 This cationic nature has also been reported 
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to limit bacterial metabolism through electrostatic stacking preventing mass transport of 
nutrients.125 chitosan has a pKa ~ 6.5, which confers pH sensitivity yielding a swollen gel or 
dissolved polymer in acidic conditions and a stable material at alkali pHs.10 Hydrogels that 
swell under acidic conditions at the early stages of wound healing may lead to enhanced cell 
infiltration and proliferation and increased oxygen permeability. 
Chitosan wound dressings are known to alter macrophage properties,202 stimulate cell 
proliferation,203 and exhibit hemostatic effects.15 Although chitosan is not native to the 
human body, its structure is similar to hyaluronic acid, which is one of the main components 
of the extracellular matrix and plays an important role in cutaneous wound healing.67,147,204 
Chitosan is enzymatically degradable and cell-adhesive.65 It can be degraded by several 
human enzymes, particularly lysozyme, which decomposes the β-(1-4)-glycosidic bonds in 
the chitosan backbone.205–207 The degradation product, N-acetyl-β-D-glucosamine, is known 
to increase fibroblast proliferation and activate hyaluronic acid synthesis, thus aiding the 
healing process.1  
In this work, we present a method for functionalizing chitosan with methacrylate 
anhydride such that the polymer can be photo crosslinked through chain-growth, step-
growth, or a combination of both mechanisms referred to as mixed model (Fig. 8).208 MAC 
based hydrogels have been reported to be biocompatible.65,66 For the chain growth 
mechanism, photopolymerization activating the carbon-carbon double bond was achieved 
using Irgacure (I2959) after degassing the polymer mixture.209 I2959 acts as an initiator to 
create a free radical under UV light. The free radical further reacts with carbon-carbon 
double bonds to form the hydrogel network.208 Gelation via step growth polymerization 
involves a thiol-ene photoclick reaction, which is different from Michael-type addition in that 
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both photoinitiator and thiol groups were required.210 The UV activated photoinitiator first 
abstracts a proton from the thiol group to generate a thiyl radical, which reacts with an alkene 
group, further forming a carbon-centered radical.211,212 In this reaction, chain growth gelation 
is quenched by oxygen.213 For mixed-model polymerization, both the step-growth and chain-
growth mechanisms were used to form the gel by introducing the thiol crosslinker and 
removing oxygen.  
 
Figure 8. Crosslink mechanism for chain growth and step growth. 
We hypothesized that the crosslinking density would change with different cross-
linking mechanisms and, therefore, the mechanical and pH responsive swelling properties 
could be tuned. It has been shown that lower stiffness materials generally results in 
successful dermal implants.202 The aim of this study was to synthesize pH sensitive hydrogels 
with various mechanical and pH-responsive properties to exam their potential application 
value as wound dressing. The expectation is to create a ‘smart’ hydrogel that may have 
applications in wound healing. 
Experiment 
Materials 
Chitosan (50-100 cps, 0.5% in 0.5% acetic acid, 87% degree of deacetylation) was 
obtained from Tokyo Chemical Industry. Other materials were purchased through Sigma and 
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were used as received, unless otherwise stated. Fresh deionized water (Milli-Q, Thermo 
Scientific Nanopure, Waltham, MA) was used throughout this study.  
Methacrylated Chitosan (MAC) synthesis  
Chitosan (900 mg) was first dissolved in 2 wt% acetic acid overnight to obtain a 3 
wt% chitosan solution. To the solution, 0.4 moles methacrylic anhydride (MA) per mole of 
chitosan repeat unit were added, which is equivalent to 340.2 mg of MA. The mixture was 
stirred and reacted for 3 h at room temperature.14 The resulting solution was a milky 
suspension that was purified by dialyzing against water for three days. The dialysate was 
changed twice daily. The solution was then lyophilized (4.5L, Labconco, Kansas City, MO) 
and the MAC was collected as a cotton-like, white solid. This reaction is illustrated in figure 
9A. 
Hydrogel gelation 
Three different gelation reactions, step growth, chain growth, and mixed-model 
polymerization, were performed in this study. In 10 ml H2O 150 mg of MAC was dissolved 
at 65 °C to make 1.5 wt% MAC. To the solution, 15 mg photoinitiator I-2959 was added. 
Step-growth gelation was achieved by adding 3 mg of dithiothreitol (DTT) to the prepared 
solution and exposing it to UV light (365 nm, 2 W/cm2) for 4 min. For chain growth, the 
solution was degassed for 30 min and then exposed to UV light for 4 min without the 
addition of DTT. For the mixed mechanism, DTT was added to the solution and the mixture 
was degassed before the mixture was exposed to UV for 4 min. 
MAC and hydrogel characterization 
NMR was used to characterize the structure and degree of methacrylation of the 
synthesized MAC. The chitosan samples were dissolved in D2O at 1 wt%. The 1H spectra 
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acquired by a Varian MR-400 spectrometer with a sweep width from -2 to 14 ppm, a 90° 
pulse, and an acquisition time of 2.556 s. VNMRJ 3.0 and MNova were used for data 
acquisition and calculation, respectively. Data was acquired with 16 repetitive scans and 64k 
points, and were processed with 128k points, zero filling, and exponential line broadening of 
1.0 Hz.  
Cylindrical hydrogels were placed between two glass slides on top of which weights 
were added. Height changes and cross-sectional areas (6 mm thick, 16 mm diameter, n = 4) 
of the hydrogel cylinders were measured through Image-J (NIH, Bethesda, MD). The 
Young’s modulus was defined as the slope of the linear region in the stress-strain curve in the 
5 – 15% strain range. 
To measure the swelling ratios, the hydrogels (n = 3) were dried at room temperature 
in a desiccator. The solid was then swelled in 1 mM acetate buffer solution at pH 3, 5, 7.4, or 
9 for 2 days. The wet and dry weights were recorded and the swelling ratios were calculated 
using equation (1), where M is the wet mass and M is the dry mass. 
S =
M − 	
	
                                                              (1) 
In vitro degradation 
For each gelation method, 1 ml of hydrogel was placed in 0.1 mM NaOH, pH 7.4 
PBS, and 0.1 mg/ml egg lysozyme to determine how reaction mechanisms affected gel 
stability and degradation profiles under the different conditions. The hydrogels were first 
equilibrated for 24 hours prior to measuring the initial mass to eliminate the swelling effect. 
The mass of the hydrogel (n = 3) was measured every 24 hours and compared with the initial 
mass.  
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Cell culture and viability assay 
NIH/3T3 fibroblasts (ATCC, Manassas, VA) were cultured at 37°C with 5% CO2 in 
complete medium (CM, Dulbecco’s modified Eagle’s medium (Thermo Scientific, Waltham, 
MA) with 10% bovine calf serum, 100 U/L penicillin, and 100 μg/mL streptomycin). To 48 
well plates, 200 μL of cell solution at 500,000 cells/ml was added to 300 μL hydrogel. After 
48 hours, the dead control was aspirated and 300 μL 70% ethanol was added for 10 mins. 
The supernatant in each well was then aspirated and replaced with 150 μL PBS with 0.3 μL 
of 1 mg/ml calcein-AM and 1.12 μL of 1 mg/ml 7-aminoactinomycin D (7-AAD) and 
incubated for 40 mins. Cells were imaged with an EVOS® FLoid® Imaging Station (Life 
Technologies, Grand Island, NY) using the red channel (excitation/emission 586/646 nm) 
and the green channel (482/532 nm). The population of live and dead cells were quantified 
using a BioTek Synergy HT Multidetection Microplate Reader (BioTek, Winooski, VT) 
using the same excitation/emission wavelengths. 
Statistical analysis. 
All data was subjected to statistical analysis and were reported as mean ± standard 
deviation. Statistical significance of the mean comparisons was determined by a two-way 
ANOVA. Pair-wise comparisons were analyzed with Tukey’s honest significant difference 
test. Differences were considered statistically significant for p < 0.05. 
Results 
Methacrylated chitosan characterization 
MAC was characterization by NMR. Figure 9 (B&C) shows the NMR spectra of 
chitosan before and after methacrylation. The peaks from 1.7 to 2.0 ppm were assigned to 
protons on the amino, hydroxyl, and methyl groups in the acetyl and methacrylamide 
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moieties. The single peak at 2.7 ppm and the broad peak at 3.5 ppm arise from the 
glucosamine ring and the methyl from the hydroxymethyl on the glucosamine ring. 
Methylene and methacrylamide peaks appear from 5.2 to 6 ppm and indicate the chitosan 
was methacrylated.65 Based on the NMR spectra, the extent of methacrylation is 23 ± 3% of 
glucosamine rings on chitosan. 
 
Figure 9. MAC synthesis reaction schematic (A) and 1H NMR spectra of chitosan (B) and 
MAC (C). 
Mechanical properties and pH response of environmentally responsive hydrogels   
Hydrogels were formed via photopolymerization using all three gelation methods 
(Fig. 10). Young’s moduli were measured for the MAC hydrogels for all three crosslinking 
mechanisms. Chitosan can be ionically crosslinked; however, physically crosslinked gels 
exhibit weak mechanical properties. Photocrosslinking of the acrylate groups in MAC can 
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overcome this limitation by introducing covalent crosslinks. The Young’s moduli for MAC 
hydrogel formed by step growth, chain growth, and mix model methods were 1.570 ± 0.183 
kPa, 3.042 ± 0.233 kPa, and 4.131 ± 0.202 kPa, respectively (Fig. 11). 
The amine moiety on the chitosan allows for the hydrogel to be responsive to changes 
in pH. Volume changes of the MAC hydrogel were measured over a range of pHs from 3 to 9 
(Fig. 12) Acetic buffer was used to stabilized pH and also eliminate salinity differences214 at 
different pHs. Significant decreases in the swelling ratios were observed when the hydrogel 
was exposed to increasingly alkali environments for all three gelation methods. The step 
growth hydrogel has a significantly higher swelling ratio than the chain growth hydrogel (p < 
0.05). The swelling ratio for the mixed model was the most dynamic over the pH 3 to 9 
range, decreasing more than 40%, while the step growth and chain growth hydrogel only 
decreased 19% and 35%, respectively. 
 
Figure 10. MAC hydrogel formed by different gelation methods: step growth (yellow); chain 
growth (blue); and mix modeled (green). (a) Hydrogel in initial form. (b) Hydrogel with 5 g 
weight applied, distinct mechanical properties observed. Food coloring was used as a dye for 
photographic purposes 
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Figure 11. Young's moduli of MAC hydrogel crosslinked through different mechanisms. 
Data represents the mean ± SD. n = 5. Statistical analysis through two-way ANOVA and 
Tukey’s HSD post-hoc test. *p < 0.05. 
 
Figure 12. Swelling behavior of MAC hydrogels under different pH. Data represents 
the mean ± SD. n = 3. Statistical analysis through two-way ANOVA and Tukey’s HSD post-
hoc test. *p < 0.05. 
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Degradation behavior 
Hydrogels synthesized from each crosslinking mechanism were exposed to 0.1 mg/ml 
lysozyme, 0.1 mM NaOH, and PBS at 37 ˚C and changes in the mass of the gel were 
recorded (Fig. 13). Degradation in lysozyme (Fig. 13A) appeared to be linear. Accelerated 
degradation was tested in NaOH (Fig. 13B) and resulted in bulk degradation, as would be 
expected for a hydrogel. Hydrogels were relatively stable in the first week with the mass 
being above 80%. Rapid degradation was observed over days 7 to 13, and the final mass was 
maintained at around 10% after 20 days incubation. PBS (Fig. 13C) was used to measure the 
ionic stability of the hydrogels. All three gels were relatively stable over 7 days, with slight 
de-swelling on day 1. No significant difference was observed between each gelation method 
under both lysozyme and NaOH degradation conditions, suggesting degradation occurred 
mainly on the chitosan backbone, rather than at the crosslink. 
 
Figure 13. MAC hydrogel degradation. Hydrogels formed through the different crosslinking 
methods were immersed in (A) 0.1 mg/ml lysozyme, (B) 0.1 mM NaOH, and (C) PBS at 37 
˚C. Data represents the mean ± SD. n = 3.  
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Cell viability 
NIH/3T3 fibroblasts were seeded on the hydrogels and analyzed via live/dead 
staining. Compared to TCP, cell proliferation was suppressed on the hydrogels (Fig. 14A). 
However, no observable cell death was found, which indicates good cell compatibility. The 
quantitative live/dead cell population was measured (Fig. 14B). The quantitative results show 
little dead cells present in any of the gels. No significant difference in cell population and 
morphology was found among the three crosslink methods. The results indicated that tunable 
modulus and swelling behavior can be achieved without changing cellular response through 
different gelation methods. 
 
Figure 14. Cytocompatibility of MAC hydrogels. NIH/3T3 fibroblasts were seeded on 
hydrogel and TCP (control). (A) Representative micrographs of live (green) and dead (red) 
cells cultured for three days. (B) Quantification of live and dead cells. Data represents the 
mean ± SD. n = 4. 
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Discussion 
Chitosan hydrogels are often used in tissue engineering and drug delivery.65,215 The 
major drawback of chitosan is that it has low solubility at neutral or alkaline pH, which 
requires modifications in order to form a hydrogel.12 Several chitosan derivatives have been 
developed to improve water solubility, such as N-carboxylethyl chitosan,60 chitosonic acid,61 
or glycidyl methacrylate chitosan.62,63 In addition, hydrogels formed via physical crosslinks 
may weaken under physiological conditions and the crosslink is generally unstable in high or 
low pH environments.17 In this study, we methacrylated chitosan.65 The advantage of this 
strategy is that further modification or chemical crosslinking can be performed with the 
carbon-carbon double bond on the methacrylate group.65,66 The objective here was to develop 
a pH-sensitive hydrogel that would swell at pH’s below 5 and shrink above pH 7.4. Potential 
applications of such a gel include releasing anti-inflammatory factors and antibiotics during 
the initial wound healing phase. The ideal hydrogel should be able to reduce the 
inflammatory response during the inflammation stage yet avoid overgrowth during 
proliferation. 
Mechanical properties and crosslink density 
Hydrogels formed by the three crosslink methods had moduli below 10 kPa. Human 
skin generally has a Young’s moduli ranging from 100 to 800 kPa, depending on the age and 
anatomical location of the skin.216 However, the hypodermal adipose layer of skin, which is 
often exposed upon injury, was reported to have a moduli under 10 kPa.217,218 In addition, 
dermal implants with lower moduli (0.7 kPa) have been found to favor dermal fibroblasts 
ingrowth,219 which is essential for wound healing. The moduli of the chitosan gels fabricated 
here were found to be adjustable through the different gelation methods, as expected since 
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the mechanical strength of hydrogels with the same backbone mainly depends on the 
crosslinking density.17 The relative order of the moduli suggests that the mixed model had 
the highest crosslinking density while the step growth model had the lowest. This might be 
due oxygen remaining in the solution after degassing, which inhibits free radical gelation.208  
Swelling behavior is another important characteristic for hydrogels.6,9 High swelling 
ratios are generally related to higher diffusion and oxygen transfer, as well as cell infiltration 
and proliferation.220 The swelling ratio is influenced by both the crosslinking density and the 
intermolecular interaction between water and polymer segments.221 Generally, large swelling 
ratios indicate a low crosslink density and high polymer hydrophilicity.14 Typically, hydrogel 
swelling is inversely related to the mechanical properties based on the crosslinking 
density.222 Hydrogels synthesized via step growth had the highest swelling ratio as expected; 
however, the mixed model showed similar or higher swelling ratio than chain growth method 
under all pH conditions (Fig. 12). This is likely because the modulus of the hydrogel is 
mainly dependent on crosslinking density and moderately related to the crosslinking 
moieties, while the swelling ratio, is significantly affected by the chemistry or hydrophilicity 
of the crosslinking molecules.214,223 DTT is more hydrophilic than the aliphatic chains 
generated under chain growth polymerization, which can influence the swelling ratio.17,224 As 
a result, the swelling ratio was inversely related to the relative crosslinking density for the 
step and mixed model fabricated gels. Gels formed through chain growth crosslinking had 
lower swelling ratios because they lacked the hydrophilic thiol crosslinker.  
pH sensitivity 
pH responsive hydrogels have attracted attention due to their controllable drug release 
kinetics and ability to undergo phase transitions at physiologically relevant conditions.6,7 
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When the environmental pH is higher than the functional group’s pKa, the cationic or anionic 
group will protonate or deprotonate, altering the hydrophobicity of the gel.8 In the case of 
chitosan based hydrogels, the amino groups (pKa 6.5)225 will be protonated at low pH and 
increase its interaction with water molecules.10 Interestingly, the swelling ratio of the 
hydrogels formed through mixed model gelation was similar to the chain growth model at 
pHs above pKa and behaved similarly to the step growth hydrogel at pHs below the pKa. 
Additionally, the hydrogel with the highest crosslinking density (mixed model) was found to 
be the most pH sensitive, while the hydrogel with the lowest crosslinking density (step 
growth) had the lowest pH sensitivity (Fig. 12). High crosslinking density generally reduces 
pH sensitivity226 and the gels synthesized here follow that trend at pH 7.4 and 9. At lower 
pHs, however, mixed model hydrogels have a similar swelling ratio as step growth formed 
gels. This may result from the more hydrophilic crosslink that is formed through crosslinking 
with the thiol along with the charge present on the amine group that further draws water into 
the network. One another possibility is that the hydrogels’ moduli was sensitive to pH.227 
Since the hydrogel shape changes after swelling, the moduli measurement of the hydrogels 
under different pHs was difficult to perform. These gels show a 19-40% reduction in volume 
when transitioning from pH 3 to pH 9, showing their ability to undergo volume changes over 
the range found in the wound healing environment.  
Hydrogel stability and degradation behavior 
Hydrogel degradation behavior is usually dependent on the crosslinking method and 
crosslink density.208 Networks formed by chain growth polymerization generally degraded 
through the crosslink segments leaving high molecular weight kinetic chains behind, while 
step growth polymerization had relatively shorter kinetic chains and could be released from 
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the network during the degradation.208 In this study, the hydrogels synthesized exhibited 
similar degradation behavior, suggesting that degradation occurs on the chitosan backbone, 
rather than at the crosslink site. Chitosan is known to degrade in lysozyme15 and was 
observed here to degrade rapidly. Degradation in NaOH results in accelerated degradation of 
chitosan.228 NaOH was originally used for chitin deacetylation to produce chitosan. After the 
deacetylation degree reached a certain value, further alkali treatment would react with the 
glycosidic bonds, resulting in degradation.229 Unlike lysozyme, small molecule such as 
NaOH can easily enter the hydrogel network and cause bulk degradation. The ionic stability 
of the hydrogels was tested in pH 7.4 PBS. Since the hydrogels were covalently crosslinked, 
no degradation was expected. 
Cytocompatibility with fibroblasts 
Wound healing is a complex biological process in which many different types of cells 
participate. One important cell type, the fibroblast, plays a major role in tissue repair and 
remodeling. Fibroblasts, together with myofibroblasts, which differentiate from these cells, 
act as a contractile bridge that pull the edges of a wound together and form extracellular 
matrix to build new tissues.5 Considering their unique role in wound healing, NIH/3T3 
fibroblasts were chosen for this in vitro study. 
Due to their hydrophilic nature, most hydrogels have low cell adhesion owing to low 
levels of protein adsorption.230 However, the cationic sites on chitosan enhance electrostatic 
interactions with the negatively charged cell membranes and proteins.231 Chitosan has been 
reported to induce fibroblast migration and proliferation both in vitro and in vivo.232 The 
chitosan hydrogels synthesized in this study resulted in no observable cell death after 2 days 
in culture, yet the cell proliferation was significantly suppressed compared to TCP (Fig. 14). 
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This may result from the decreased mechanical properties219 of the hydrogel compared to 
TCP. Human dermal fibroblasts are known to preferentially attach to stiffer substrates and 
have a higher proliferation rate on those substrates,233 which is in line with our observations. 
The chitosan concentration in the hydrogel could also alter cell adhesion and growth rates. 
Another reason could be the reactive free radicals generated by the photopolymerization 
method, which was often reported to decrease cell viability.234,235 Low stiffness materials are 
favorable for wound healing and dermal implant applications219 since they have similar 
mechanical properties as human skin. Since these gels are able to swell in response to the 
surrounding pH, there may be applications for these materials in releasing anti-inflammatory 
drugs during the early stages of wound healing, thus improving healing outcomes.4 
Conclusions 
In this study, the MAC based hydrogels were crosslinked via three different 
mechanisms: chain growth, step growth, and a mixture of both, termed mixed model. The 
hydrogels were observed to have Young’s moduli similar to implants that have been 
successfully used as dermal implants and are highly pH responsive over the range typical for 
the healing process at cutaneous wound sites. Tunable mechanical properties and different 
degrees of pH sensitivities could be achieved by adjusting the gelation method. The 
hydrogels fabricated here were degradable both in accelerated basic conditions and 
enzymatically, while being stable in neutral buffer. Little to no toxicity for fibroblasts 
cultured on these hydrogels was observed. These results indicated that MAC hydrogels have 
a potential application in responding to specific wound healing stages by pH dependence and 
accelerate wound healing.  
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Degree of Deacetylation 
The DD of chitosan can alter cellular responses and in a non-linear manner.202 
Chitosan with 85-89% DD largely increases cell adhesion compared to chitosan with 95% 
and 58% DD.128,129 Taking this into account, MAC hydrogels with different DD were 
synthesized to study their effects on cellular response.  In addition, in the MAC hydrogel 
system the deacetylation could possibly change the reaction extent since the amount of amino 
group available to be methacrylated would be altered. 
To investigate the effect of DD on MAC hydrogels, chitosan with 93% DD was 
studied. The chitosan (DD = 87%) was first deacetylated in 47% NaOH at 60˚C under 
nitrogen for 2h, then rinsed with hot water. Mild reaction conditions were used to suppress 
chitosan degradation.229 The resulting chitosan was found to have a DD of 93% by NMR236 
and was methacrylated using the same procedure described above. The resulting polymer, 
deacetylated MAC (MAC-D), was crosslinked and characterized as described above. The 
chemical properties and compression moduli of MAC-D are listed in table 1. The swelling 
behavior under different pHs is shown in figure 15.  
Table 1. Chemical and mechanical properties of MAC and MAC-D 
 MAC D-MAC 
DD % 87 ± 2 92 ± 1 
Methacrylation degree % 26 ± 3 23 ± 4 
Compression 
Modulus 
(Pa) 
Step growth 1570 ± 183 1889 ± 149 
Chain growth 3042 ± 233 2294 ± 457 
Mixed model 4131 ± 201 4124 ± 415 
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Compared to MAC hydrogels, MAC-D has a significantly lower modulus when 
crosslinked by the chain growth mechanism. The swelling differed for step growth at pH 5, 
chain growth at pH 3, and mixed model at pH 9. However, MAC-D compare to MAC, 
showed a larger decrease in swelling ratio between pH 3 and pH 5, and a smaller decrease 
when pH changed from 5 to 9. In other words, the result suggested a shift in pH sensitivity 
point after deacetylation.  
 
Figure 15. Swelling behavior of MAC-D hydrogel compare to MAC at different pH. (* 
P<0.05) 
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CHAPTER V 
SUPRAMOLECULAR ASSEMBLIES OF ALKANE FUNCTIONALIZED 
POLYETHYLENE GLYCOL COPOLYMERS FOR DRUG DELIVERY 
 
Abstract 
Surfactants are commonly used drug carriers, however, there is a lack of 
understanding regarding the relationship between drug loading, drug release kinetics, and cell 
internalization with the physicochemical properties of the drug carriers, preventing rational 
design. The effects of altering hydrophobic and hydrophilic chain lengths on a poly[poly-
(oxyethylene)-oxy-5-hydroxyisophthaloyl] (Ppeg) platform for delivering hydrophobic drugs 
was examined. The synthesized polymers were characterized by nuclear magnetic resonance 
spectroscopy (NMR), dynamic light scattering (DLS), and zeta potential. The resulting 
polymer particles were able to form micelles in aqueous solution and encapsulate pyrene, a 
highly hydrophobic model drug, with a loading capacity up to 8 wt%, corresponding to a 
50% loading efficiency. The ability to sustain drug release from these micelles over several 
days was also observed. RAW 264.7 macrophage uptake of the micelles was measured 
quantitatively and was found to be substantially higher than internalization of the 
unencapsulated drug. The loading capacity of the drug in the various micelles did not 
correlate with the internalization of the particles into the cells. Factorial analysis was used to 
develop predictive equations for drug loading, drug release kinetics, and cell internalization. 
These models were validated with newly synthesized compounds.   
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Introduction 
Delivery of many drugs is limited by water solubility, short in vivo half-life, and 
hydrolysis.237 Polymeric delivery vehicles must strike a balance between the binding strength 
with the drug molecule and the ability to release this material in cells.238 Surfactants, 
particularly biosurfactants, present an attractive possibility for drug delivery owing to their 
biodegradability and chemical sensitivity to temperature and pH.34 Due to the amphiphilic 
nature of surfactants, hydrophobic drugs can be encapsulated in a micellular form. These 
surfactants are known to complex around drug molecules or to form micelles above the 
critical micelle concentration (CMC). 
Previous work has compared surfactants with different hydrophobic or hydrophilic 
chain lengths and the hydrophilic-lipophilic balance (HLB) with their CMCs.239,240 These 
surfactant systems have sometimes yielded conflicting results. For instance, some studies 
have shown that the hydrophilic chain length did not have a significant effect on CMC241 
while others found that longer hydrophilic chains resulted in a higher CMC in polyethylene 
glycol (PEG) ylated phospholipids.21 The relationship between drug delivery properties and 
the hydrophobic/hydrophilic chain length of the surfactant remains unclear. Developing 
design principles for these systems remains a critical challenge for researchers in drug 
delivery. Some methods that have been used for developing such principles for drug delivery 
include mathematical models, such as quantitative structure-activity relationships,242,243 or 
statistical methods to determine materials properties that influence outcomes, such as 
principal component analysis.244–250 Here, we employ factorial analysis, which uses linear 
relationships between materials properties to develop a prediction for an outcome. This 
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method has been previously employed to optimize particle size,251–253 entrapment efficacy,253 
and polydispersity.253 
PEG was selected as the hydrophilic block in the amphiphilic polymers synthesized in 
this research for its stealth capabilities for drug delivery in vivo.43 Several efficient 
copolymer preparation methods have been developed using PEG as a polymeric block.49–52 
One of these mechanisms couples PEG and dimethyl 5-hydroxyisophthalate to form a 
copolymer.80 The resulting product, Ppeg, is an amphiphilic polymer.81 Through further 
modification of the copolymer by conjugating alkyl chains to the isophthalate moiety, the 
polymer can self-assemble in aqueous solution. Based on light scattering experiments, the 
synthesized polymers could form micelles with a hydrophilic PEG shell and a hydrophobic 
core with aromatic units.82  
Developing predictive algorithms for internalization of micelles using the 
hydrophobic and hydrophilic properties of the copolymer has not yet been achieved. Polymer 
properties influence particle internalization by macrophages.254–256 Macrophages derive from 
monocytes and maintain a unique role in innate immunity,58 adaptive immunity, and tumor 
angiogenesis and migration.56 In this research, Ppeg modified with bromoalkanes with chain 
lengths from C6 to C11 were synthesized. By using PEG and alkyl chains of varying 
molecular weights, the effects of altering the hydrophilic shell and hydrophobic core on 
internalization by RAW 264.7 macrophages could be examined. The polymers synthesized 
were characterized for their size, pH dependent surface charge, and temperature dependent 
CMC. The polymers were loaded with a model hydrophobic drug, pyrene, and the release 
kinetics at pH 5 and 7.4 were measured.  
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Experimental  
Materials  
All materials were purchased through Sigma and were used as received, unless 
otherwise stated. Fresh deionized water (Milli-Q, Thermo Scientific Nanopure) was used 
throughout this study. Poly ethylene glycol MW 600/1000 (PEG 600/1000) was dried under 
vacuum for 24 h prior to use. Dimethyl 5-hydroxyisophthalate and novozyme-435 were dried 
in a desiccator before use.  
Polymer synthesis 
Equimolar (1 mmol) PEG 600/1000 and dimethyl 5-hydroxyisophthalate were mixed 
in a round bottom flask. To this mixture novozyme-435 (10 wt%) was added. The reactor 
was maintained under vacuum in a 90°C oil bath for 48 h. The reaction was quenched with 
water and was filtered under vacuum. The filtrate was then dialyzed for 12 h in Milli-Q water 
using a 3,500 molecular weight cut off membrane and was lyophilized (Labconco, 4.5L) to 
obtain the product. The reaction schematic is shown in figure 16. At room temperature, the 
poly[poly(oxyethylene-600)-oxy-5-hydroxyisophthaloyl] (Ppeg-600) obtained was a 
yellowish mucinous fluid and the poly[poly(oxyethylene-1000)-oxy-5-hydroxyisophthaloyl] 
(Ppeg-1000) was a white solid. 
Equimolar (1 mmol monomer) of Ppeg-600/1000 and bromoalkanes were mixed in 
10 mL dry acetone in a round bottom flask. The bromoalkanes used in this study were 1-
bromohexane, 1-bromoheptane, 1-bromooctane, 1-bromononane, 1-bromodecane, and 1-
bromoundecane. To the solution 1 mmol anhydrous potassium carbonate was added. The 
mixture was maintained at 60°C in a water bath for 12 h. The potassium carbonate was 
removed through filtration. Acetone was removed by vacuum and the product was dialyzed 
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for 4 h in Milli-Q water and lyophilized. This yielded poly[poly(oxyethylene-600/1000)-oxy-
5-(alkane)-isophthaloyl] (Ppeg-600/1000-alkane).  
 
Figure 16. Reaction scheme for polymerization of Ppeg. A) PEG and dimethyl 5-
hydroxyisophthalate were conjugated with novozyme-435 under 90°C to form poly[poly 
(oxyethylene)-oxy-5-hydroxyisophthaloyl]. B) poly[(poly- (oxyethylene)-oxy-5-
hydroxyisophthaloyl] is reacted with bromoalkane at 60°C to form poly[poly(oxyethylene)-
oxy-5-(alkane)-isophthaloyl]. 
Polymer Characterization 
NMR was used to determine the structure and % alkyl modification of the polymers. 
The 1H spectra were recorded on a Varian MR-400 spectrometer with a sweep width from -2 
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to 14 ppm, a 90° pulse, and an acquisition time of 2.556 s. All spectra were obtained at room 
temperature at a concentration of 1 wt% in D2O. VNMRJ 3.0 was used for data acquisition. 
Sixteen repetitive scans with 64k points were acquired and the data were processed in 
MNova with 128k points, zero filling, and exponential line broadening of 1.0 Hz.  
Zeta potential, weight average molecular weight, and micelle size were measured 
using a Zetasizer Nano Z (Malvern). Zeta potential was determined at a concentration of 1 
wt% in 100 mM NaCl at pH 5 and pH 7.4 at 25°C. The weight average molecular weight was 
tested in methanol at various concentrations. The size of the micelle was measure using DLS. 
Ppeg-600/1000-alkane micelles were tested at 1 wt-% in Milli-Q water at 25°C. The CMC 
was measured as a change in particle size. Particles were tested from 0.003% to 1.0% in 
water at 5, 25, and 35°C.  
Drug loading and release  
Pyrene was used as a model hydrophobic drug. Pyrene and Ppeg-600/1000-alkane 
were mixed in acetone at a mass ratio of 1.5:10 (drug: polymer). The solvent was removed 
under vacuum and the loaded particles were lyophilized. The solid sample was then re-
dispersed in Milli-Q water at 0.1 wt% and mixed using a vortexer. The mixture was 
centrifuged at 200 g for 5 min to separate unloaded pyrene. To a black 96 well plate, 50 μL 
of 0.1 wt% pyrene loaded Ppeg-600/1000-alkane was added. The micelle structure was 
broken and the encapsulated pyrene was released through the addition of 150 μL of dimethyl 
sulfoxide (DMSO, Fisher) to each well. A standard curve was made through a serial dilution. 
Fluorescence of the pyrene was measured using a plate reader (BioTek Synergy HT 
Multidetection Microplate Reader) at an excitation/emission of 360/460 nm. 
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Pyrene loaded Ppeg-alkane (1 mL of 0.1 wt%) was added to a dialysis membrane and 
placed a in a small beaker with 100 mL of phosphate buffered saline (PBS). The pH of the 
PBS was maintained at pH 5 or 7.4. The beaker was sealed and incubated at 37°C. Aliquots 
of 1.5mL of the dialysate were taken at 4 h, 12 h, 24 h, and every 24 h for the next 3 days. 
After each time point, the dialysate was removed and refreshed to avoid pyrene reaching its 
maximum solubility and suspending the release. After sampling was complete, 50 μL of each 
sample (five replicates for each time point) was added to a black 96-well plate with 50 μL 
DMSO. The standard curve was made through a serial dilution. The plate was read at 
360/460 nm.  
Cell viability and particle internalization 
RAW 264.7 cells (ATCC) were cultured at 37°C with 5% CO2 in Dulbecco’s 
modified Eagle’s medium (Thermo Scientific), which was supplemented with 10% fetal 
bovine serum, 100 U/L penicillin, and 100 μg/mL streptomycin (complete medium, CM). 
Cells (1.6 × 105 cells/cm2 in 100 μL of media in every well except the negative control) were 
seeded into a 96 well plate for 24 h. Particles were added to the plate at concentrations of 
0.02 wt% Ppeg-600 alkane and 0.05 wt% Ppeg-1000-alkane, with and without pyrene 
loading. Unencapsulated pyrene was also tested at the same concentration. These plates were 
then used to measure cell viability or particle internalization. 
For cell viability experiments, after 4 h incubation with the particles described above, 
the media was aspirated and 10 μL of 5 mg/mL 3-(4, 5-dimethyltiazol-2-yl)-2, 5-
diphenyltetrazolium bromide (MTT) and 100 μL CM without phenol red were added to each 
well. The plate was incubated at 37°C for 4 h. The CM was aspirated from each well and 100 
μL DMSO was added to dissolve the formazan crystals. The optical density at 540 nm and a 
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reference of 690 nm were measured with a plate reader. Data was normalized to cells 
cultured without particles or pyrene and 10 replicates were obtained for each condition. 
For particle internalization experiments, after 4 h incubation with the particles as 
described above, the CM was aspirated and washed with PBS. The black 96 well plate was 
read at 360/460 nm. Cold binding experiments were also performed by incubating the 
particles with cells at 4°C for 4 h. Ten replicates were obtained for each particle. 
Unencapsulated pyrene was used as a control. 
Cell imaging 
Cells were seeded at a density of 5.6 × 104 cells/cm2 in tissue culture-treated Petri 
dishes (Corning) for 24 h at 37°C. The cells were then incubated for 4 h with 0.02 wt% Ppeg-
600 alkane or 0.05 wt% Ppeg-1000-alkane particles loaded with pyrene at 37°C or 4°C. Next, 
the CM was aspirated and the Petri dish was washed with PBS. Images were obtained with a 
FLoid cell imaging station (Life Technologies). 
Statistical and factorial analysis 
All data was subjected to statistical analysis and were reported as mean ± standard 
deviation. Statistical analysis was done using JMP® statistical software (Cary, NC). 
Statistical significance of the mean comparisons was determined by a two-way ANOVA. 
Pair-wise comparisons were analyzed with Tukey’s honest significant different test. 
Differences were considered statistically significant for p < 0.05. The relationship between 
physicochemical properties (PEG chain length, alkyl chain length, and HLB values) and drug 
loading, drug release, and cell internalization was analyzed using factorial analysis through 
JMP®.  
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Results 
Polymer characterization 
NMR characterization of the synthesized polymers confirmed the reaction proceeded 
as expected (Appendix B). Base on the NMR spectra, the reaction ratio between PEG 
600/1000 and 5-hydroxyisophthalate along with the % of the isophthalate modified with 
bromoalkane was calculated. Ppeg-600 has a PEG chain to isophthalate mole ratio of 1.06 ± 
0.09, and Ppeg-1000 reached 1.07 ± 0.11. A ratio of 1:1 represents a linear alternating 
copolymer structure. The alkane chain-attachment percentage was calculated as the reaction 
extent and has an average of 51.6% (Appendix D). The alkyl chains are abbreviated to the 
first three letters of the alkane throughout this paper. 
Weight average molecular weight and micelle size was determined by DLS using the 
intensity distribution method. The polydispersity index (PDI) ranged from 0.09 to 0.23 for all 
the particles. The weight average molecular weight of Ppeg-600 and Ppeg-1000 polymer was 
found to be 18±4 kDa and 38±7 kDa, respectively. There were no statistical differences 
between the sizes of the various micelles with the average micelle size being 12 nm 
(Appendix D).  
Zeta potential measurements of the particles at pH 5 and 7.4 are shown in Figure 
17A. Since the polymer mainly contains PEG and alkyl chains, in which the PEG chain is 
slightly negatively charged and the alkyl chain is slightly positively charged, the polymer 
surface was relatively neutral. The experimental data shows that all the micelles have a 
slightly negative zeta potential since the zeta potential arises from the chemical moieties 
present at the surface, which are PEG chains. 
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Figure 17. Zeta potential, CMC, and drug loading capacity of Ppeg-alkanes. (A) Zeta 
potential of 1 wt% of Ppeg-alkanes in 0.1 M NaCl solution. (*) indicates p < 0.05 compared 
with the control (0.1 M NaCl) by pairwise comparison. (+) indicates p < 0.05 for micelles at 
pH 7.4 compared with those at pH 5. (B) CMC of the synthesized polymers in Milli-Q water 
at 5, 25, 35°C. (C) The loading capacity of pyrene encapsulated in the micelles at 0.1% in 
Milli-Q water. Bars with the same letter (A - G) are not statistically different (p < 0.05). 
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The CMCs of the Ppeg-alkyl micelles at three different temperatures are shown in 
Figure 17B with each temperature corresponding to a specific cell culture environment: 5°C 
to cold binding (4°C); 25°C to room temperature; and 35°C to body temperature (37°C). The 
CMC of Ppeg-600-hexane and -heptane at 35°C were not listed because they were below the 
detection limit (< 0.003%). Both hydrophobic and hydrophilic chain length are known to 
alter the CMC.257 On average, the Ppeg-600-alkane polymers had lower CMCs than the 
Ppeg-1000-alkanes. Temperature is another factor known to affect dipole forces and change 
the CMC.257 However, based on the data presented, most of the micelles synthesized for 
these experiments did not show a dependence on temperature.  
Drug loading and release 
The loading capacity data (Figure 17C) had the reverse trend observed for the CMCs: 
particles with lower CMCs have higher loading capacity. Interestingly, Ppeg-600-alkanes had 
a higher loading capacity than Ppeg-1000-alkanes when the alkane chain length was 6 to 8 
carbon. This relationship reversed when the alkane chain length was at least 9 carbons. Ppeg-
600-oct had the highest loading capacity of the Ppeg-600 polymers, while Ppeg-1000-non 
had the highest loading among the Ppeg-1000 polymers. These results suggested there could 
be an inflection point in drug loading behavior corresponding to alkyl chain length. 
The release kinetics of pyrene from the micelles is shown for pH 5 and pH 7.4 at 
37°C in figure 18A-D. The cumulative percent released at 96 h is shown in figure 18E for 
comparison. All the particles released drug in a linear manner after 96 h. Ppeg-600 particles 
released less than 20% of their loaded drug at 96 h, indicating sustained release of pyrene 
from the micelles. However, Ppeg-1000-particles had shorter drug release times. Apart from 
Ppeg-1000-dec, the cumulative % release at pH 7.4 exhibits a similar trend as the CMC and  
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Figure 18. Pyrene release from Ppeg-alkyl micelles. Pyrene was released from Ppeg-alkane 
in PBS at 37°C: A&B) Pyrene release from Ppeg-600-alkane at pH 7.4 and pH 5, 
respectively. C&D) Pyrene release from Ppeg-1000-alkane at pH 7.4 and pH 5, respectively. 
E) Cumulative pyrene release % from the Ppeg-600/1000-alkane micelles at pH 7.4 and pH 5 
at 96 h. (*) indicates p < 0.05 for micelles at pH 7.4 compared with those at pH 5. 
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is inversely related to drug loading. With sufficient core-drug compatibility, a stronger 
binding ability implies a lower CMC and a more stable micelle since this results in a lower 
free energy.40 Thus, lower CMCs should result in higher loading and slower release. All 
Ppeg-alkane particles exhibited a faster release rate in pH 7.4 than pH 5.  
To further explain the release behavior, the data was modeled using a general release 
equation: 
 =  ∗                                                              (2) 
Where r is the release % at time t, k is the release rate constant, and n is the rate order. 
The kinetic coefficients obtained from the model are listed in Appendix E. All polymers 
showed reduced release rate constants at pH 5 compared to pH 7.4. Ppeg-1000-alkanes 
generally had higher release rate constants at both pH 7.4 and pH 5 compared with their 
Ppeg-600 counterparts. With a few exceptions (Ppeg600-dec at pH 7.4 and Ppeg600-und, 
Ppeg1000-hex, Ppeg1000-dec, and Ppeg1000-und at pH 5), the calculated rate order was 0.2-
0.4 for the micelles. 
Cell viability and particle internalization 
The cytocompatibility of the particles was determined using an MTT cell viability 
assay on RAW 264.7 macrophages. The viability of the cells cultured with the Ppeg-
600/1000-alkane particles was expressed as a percentage of cell viability of cells not exposed 
to the particles and is shown in Figure 19. To ensure micelle formation, the Ppeg-600-alkane 
particles were tested at 0.02% and Ppeg-1000-alkane particles at 0.05%. Most polymers, 
except Ppeg-600-hex/hep, were cytocompatible after 4 h incubation. The average cell 
viability of Ppeg-600-alkanes and Ppeg-1000-alkanes was 87% and 84%, respectively. After 
loading with pyrene, Ppeg-1000-non showed more toxicity while significant changes were 
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not observed for the other particles. Unencapsulated pyrene results in nearly 100% viability. 
We hypothesized that pyrene itself is not internalized by the cell owing to its low water 
solubility (0.135 mg/L) and therefore did not cause any cytotoxicity. However, micelle 
encapsulation allows pyrene to enter the cell and increases toxicity in the case of Ppeg-1000-
non/dec. The remaining polymers did not show a decrease in viability possibly due to 
insufficient quantities of pyrene being internalized by the cell necessary to induce toxic 
effects. 
 
Figure 19. Cell viability of Ppeg-alkyl polymers. Cell viability was measured by an MTT 
viability assay after 4 h incubation with micelles or pyrene-loaded micelles. Cell viability 
was normalized to cells without micelles or pyrene. Unencapsulated pyrene is used as a 
control. 
73 
 
Images of the pyrene loaded particles being internalized by macrophages are shown 
in figure 20A. Pyrene is naturally fluorescent, allowing for direct imaging. Pyrene could 
enter the cells when encapsulated in the particles. Pure pyrene showed no detectable cell 
internalization with the only fluorescence signal arising from a pyrene crystal that formed on 
the bottom of the Petri dish. The cells become more spherically shaped upon exposure to 
Ppeg-600-hexane, which generally indicates toxicity. The fluorescence images of cell 
internalization of these particles incubated at 4°C are shown in Appendix C. At 4°C, active 
cell internalization pathways are blocked, meaning any fluorescence signal observed at this 
temperature likely results from micelles adsorbed to the cell surface. None of the Ppeg-
alkanes had an observable signal at 4°C, which indicated that the micelles were internalized 
through active transport, rather than passive transport, and were not adsorbed to the surface 
of the cells. 
Figure 20B shows the fluorescence level of encapsulated pyrene internalized or 
associated with RAW 264.7 macrophages. As observed in the qualitative images (Fig. 20A), 
the results showed a significant increase when incubation temperature was increased from 
4°C to 37°C apart from Ppeg-600-dec, Ppeg-600-und, and pure pyrene, which have very low 
levels of pyrene internalization. The highest fluorescence level was observed for Ppeg-1000-
non and agrees with our hypothesis that a decrease in viability for this particle results from 
enhanced pyrene internalization.  
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Figure 20. Internalization of pyrene-loaded micelles in macrophages. (A) Cells were 
incubated for 4 h at 37°C with the pyrene (blue) loaded polymers. The scale bar represents 
100 μm. (B) Cell internalization was measured after 4 h incubation with pyrene-loaded 
polymers at 37°C and 4°C. (*) indicates p < 0.05 for micelles at 37°C compared with those at 
4°C. (C) Cell internalization normalized to the amount of pyrene per unit mass of polymer to 
show the amount of polymer internalized. Bars with the same letter (A - F) are not 
statistically different (p < 0.05). 
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To compare the performance of each polymer, the amount of pyrene added to each 
well was calculated, and the fluorescent signal was normalized (Fig. 20C). The results 
demonstrate that the Ppeg-1000-alkane particles have higher cell internalization than the 
Ppeg-600-alkane particles. Significant differences between Ppeg-600-alkane and Ppeg-1000-
alkane particles were observed. However, relatively low differences were found between 
polymers with the same PEG chain length, indicating that cell uptake is not altered by alkane 
modification.  
Factorial Analysis 
Factorial analysis is a statistical method that uses linear combinations of descriptors 
to predict an observable. In this case, we used the chain lengths of the PEG and alkyls used to 
fabricate the particles and their resulting HLB values. The HLB value is calculated using 
equation 3, where MWhydrophilic is the molecular weight of the hydrophilic portion, or the PEG 
chain, and MWtotal is the total molecular weight of the polymer.  
 = 20
 ! "
##$!
               (3) 
The correlation map (Fig. 21A) shows the relationship between each of the 
observables and the descriptors. The PEG molecular weight is positively correlated with cell 
internalization (R = 0.87). As previously mentioned, the CMC is positively related to drug 
release (R = 0.73 for pH 7.4 and 0.83 for pH 5) and negatively related to loading capacity (R 
= -0.58). This likely results from micelle stability as lower CMC values indicate higher 
stability and lower free energy. Thus, the micelle can encapsulate more drug and remain 
stable. Interestingly, the cell viability of the micelles in the absence of pyrene is negatively 
related to pyrene loading capacity. No relationships were found for zeta potential and micelle 
size with the observables and descriptors.  
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Figure 21. Factorial analysis on the effect of PEG/alkyl chain length to drug delivery 
parameters. (A) Correlation map of PEG molecular weight, alkyl molecular weight, HLB 
value, pyrene release % at pH 7.4 and 5 at 96 h, pyrene loading, CMC, zeta potential at pH 
7.4 & 5, micelle size, cell viability with the copolymers, and the normalized cell 
internalization of pyrene loaded micelles. Red denotes a positive relationship, while blue 
denotes a negative relationship. (B) Plots of predicted loading capacity, drug release at 96 h 
at pH 7.4, and cell internalization vs. experimentally determined (observed) values. The 
results for the statistics of the model were the following: R2 = 0.79, 0.78, and 0.97 for the 
modeled parameters, respectively. Red data points represent Ppeg-600-und-91% and Ppeg-
1000-dec-72%. The dashed line is y = x. 
To derive design principles for this system, three factors of drug delivery behavior 
were considered as functions of PEG molecular weight, alkane molecular weight, and HLB 
values: drug loading, drug release, and cell internalization. A prediction for these behaviors 
can be calculated as: 
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) ∗ 107 = 2.109 − 4.14- − 492< − 0.1069- −
0.2779< − 0.961-< + 0.007559-< + 11100       (4) 
ABCB&DB % (, 7.4 & 96ℎ) = 6.959 + 45.8- + 252< − 0.07359- − 0.3909< −
2.62-< + 0.004209-< − 0.00445         (5) 
I)B)&C(<&(%) = −6709 − 2960- − 22600< + 4.989- + 38.59< + 169-< −
0.2859-< + 395000          (6) 
where x is the PEG molecular weight; y is the alkyl chain molecular weight, and z is 
the HLB value (Fig. 21B). The R2 statistics of the model were: 0.79, 0.78, and 0.97 for drug 
loading, drug release, and cell internalization, respectively.  
Next, these model equations were validated by synthesizing Ppeg-600-und-91 and 
Ppeg-1000-dec-72. The last number signifies the % attachment of the alkyl chain to the 
hydroxyl on the isophthalate and was accomplished through altering the reaction time with 
the bromoalkane. These polymers were characterized for size, zeta potential, CMC, loading 
capacity, and drug release at pH 5 and 7.4. The cell viability in the presence of these micelles 
and the internalization of the micelles by RAW 264.7 macrophages was also measured 
(Table 2). The drug loading, drug release, and particle internalization of Ppeg-600-und-91 
and Ppeg-1000-dec-72 are shown in figure 21B as red data points using equations 4-6 to 
predict the observed values. As can be seen in figure 21B, equations 4-6 accurately predict 
the observed values for all three cases. 
Discussion 
Polymer drug delivery properties 
In our surfactant system, several polymers showed pH sensitivity. Changes in pH can 
often affect surfactant performance.33,45,258 Low pH can cause ether bond protonation in the 
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PEG chain and change the molecular charge towards a more positive charge.33 The zeta 
potential showed that all particles tested here were slightly negatively charged, thus a change 
in pH could reverse the surface charge of the micelles. The Ppeg-600-alkane particles 
changed very modestly; however, several Ppeg-1000 polymers showed significant increases 
in their zeta potentials. Ppeg-600-alkanes were less affected since the pH mainly affects the 
PEG chain, which is nearly doubled for the Ppeg-1000-alkanes.  
The zeta potential is slightly more negative for Ppeg-1000 particles than Ppeg-600 
particles at pH 7.4. The main factor altering the zeta potential is the hydrophilic PEG shell, 
whose surface charge increases with molecular weight.257 Zeta potential is a measure not 
only of surface charge, but the electric charge on the slipping plane between the bulk solution 
and the stationary layer.259 Ionically separated systems increase in stability when the absolute 
value of the measured zeta potential increases,260 while the stability of sterically separated 
systems does not depend on the zeta potential.261,262 Since the polymer itself is neutral and 
the pH study on pyrene release (Fig. 18) suggested that the micelles are more stable at pH 5, 
which has lower absolute values of the zeta potential, the system should be sterically 
stabilized regardless of the measured zeta potential. However, the negative charge mainly 
arises from the ether bonds in the PEG chain that have decisive roles in hydrogen bonding. 
The larger negative zeta potential represents a higher activity of the ether bond, which relates 
to hydrogen bond formation263 or the hydrophilicity of the PEG chain. This leads to 
increasing hydrophobic forces, which favor micelle stability.40 As a result, a more positive 
zeta potential implies a more stable system. This is further substantiated by the zeta potential 
data at pH 5, which showed that ether bond protonation caused by the lower pH33 resulted in 
a less negative zeta potential and enhanced micelle stability. One possible explanation is that 
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the Ppeg-1000 particles are capable of additional hydrogen bonding, requiring additional 
energy to form a micelle and that the added flexibility of the hydrophilic shell may affect 
PEG chain arrangement and cause a change in the zeta potential. 
Table 2. Characterization of polymers synthesized to validate equations 4-6. Ppeg-600-und-
91% and Ppeg-1000-dec-72% were synthesized with different alkane % modification and 
characterized for their HLB values, micelle size, Zeta potential at pH 5 and 7.4, CMC, 
loading capacity, drug release at pH 5 and 7.4, cell viability, and internalization by RAW 
264.7 macrophages. 
 Ppeg-600-und-91% Ppeg-1000-dec-72% 
HLB 14.4 16.8 
Size (nm) 14.9±5.0 9.3±2.7 
Zeta (mV) 
pH 7.4 -4.25±0.82 -3.70±0.66 
pH 5 -2.13±0.67 -2.52±0.93 
CMC (wt %) 0.001±0.001 0.004±0.001 
Loading capacity  
(mg/mg polymer) 
0.030±0.003 0.033±0.003 
Drug release % 
pH 7.4 4.09±0.52 5.66±0.68 
pH 5 4.61±1.03 2.88±0.72 
Cell viability  
(% to control) 
44.7±8.2 53.9±4.7 
Internalization 
fluorescence 
level 
37 ˚C 436±203 7323±1150 
4 ˚C 169±78 1350±178 
Normalized internalization 358±170 2230±394 
 
Drug release kinetics were analyzed using a general release equation (eq. 2). The 
release rate constant is associated with structural characteristics while n can be used to 
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determine the release mechanism. For spheres such as micelle structures, an n smaller than 
0.43 indicates a Fickian diffusion dominated release; n larger than 0.85 indicates a chain 
relaxation, such as swelling or micelle deformation dominated release; and an n between 0.43 
and 0.85 indicates a mixture of both release mechanisms.9,264 Based on the fitting parameters 
obtained in Appendix E., the polymer micelles underwent Fickian diffusion at pH 7.4 with 
the exception of Ppeg-600-dec. Interestingly, several polymers such as Ppeg-600-und and 
Ppeg-1000-hex followed Fickian diffusion at pH 7.4 but switch to Fickian-chain relaxation 
mixed release at pH 5 as n increased significantly. The rate constant decreased sharply when 
the pH drop from 7.4 to 5 and, as an overall outcome, the drug release rate was slower at 
lower pH. Overall most of the polymers followed Fickian diffusion at both pH 7.4 and pH 5.  
Cell viability data showed cytocompatibility of the Ppeg-alkane particles when 
cultured for 4 h with RAW 264.7 macrophages, with Ppeg-600-hexane and –heptane being 
the least cytocompatible (67 and 70% viability, respectively). The toxicity of Ppeg-600-hex 
and -hep could be the result of biodegradation. Biodegradation of ethoxylate based linear 
surfactants is known to have two different mechanisms that occur simultaneously: cracking at 
the ether group between the PEG chain and the alkyl group and cracking at the end groups.257 
After endocytosis by cells, the micelle structure will open up in the lysosome and release the 
drug encapsulated inside. Thus, there is a possibility that isophthalate was released as a 
degradation product. Furthermore, PEG chains with lower molecular weights can be more 
easily degraded into oligomers and their hydroxyl acids. This could lead to an increase in 
metabolic acidosis, calcium levels, and serum osmolarity.265 Changes in calcium levels and 
osmolarity could lead to plasma membrane potential decreases and dehydration. The micelle 
structure of the studied polymers requires a folded PEG chain, which favors intermolecular 
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hydrogen bonding. For Ppeg-600-hex and -hep, the degradation process is faster than other 
particles because the alkyl chain is shorter and the PEG chain also has a lower molecular 
weight. Unencapsulated pyrene was shown to be nontoxic; however, cell imaging and cell 
uptake data showed that pure pyrene is not internalized. Considering this, the decrease in the 
viability of RAW 264.7 macrophages exposed to pyrene loaded Ppeg-1000-non viability 
after loading with pyrene compared with the polymer in the absence of pyrene may result 
from the ability to deliver cytotoxic quantities pyrene to the cell. Such a supposition is 
consistent with the cell uptake results shown in figure 20 where Ppeg-1000-non had the 
highest pyrene uptake. 
All polymers, except Ppeg-600-dec and –und, showed a significant improvement in 
cell uptake compared to pure pyrene. PEG is often used as a ‘stealth coat’ to prevent particle 
clearance by the circulation system and reduce macrophage internalization by inhibiting 
protein adsorption.39 Internalization was found to depend on the PEG chain length rather than 
alkyl chain length (Fig. 21A). 
Drug delivery behavior relationship with hydrophilic/hydrophobic chain length 
To study the relationship between drug delivery parameters and 
hydrophobic/hydrophilic chain lengths, several properties such as zeta potential, CMC, drug 
loading/release, and cellular responses were compared to the PEG and alkyl chain lengths. 
Since the alkane modification rate is not the same for all of the polymers (43% to 68%), we 
introduced the HLB value to offset this difference. The performance of surfactants is highly 
dependent on the HLB value.35 It is also an indicator of surfactant drug delivery behavior.266 
In examining the effect of the PEG chain length on the CMCs (Fig. 17B & 21A), the 
results exhibit an increase in CMC with increasing PEG chain length (R = 0.52) and a 
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decrease with increasing alkyl chain (R = -0.55). The CMC is an important index for micelle 
mediated drug delivery systems.267 The increasing alkyl chain length increases the number of 
van der Waals interactions present in the core of the micelle, thus decreasing the CMC. The 
increase in CMC when comparing Ppeg-600 polymers to the Ppeg-1000 polymers arises 
from the increased hydrogen bonding between water and the PEG chain, preventing micelle 
formation. Typically, the CMC of surfactants with similar hydrophilic groups decreases 
logarithmically with increases in the number of carbons in the alkyl chain using the following 
equation: 
 log(M	M) = N − )     (7) 
where n is the number of carbons in the alkyl residue and A, B are constants.257 The 
Ppeg-1000 micelles generally followed this trend. The CMC increases in Ppeg-600 polymers 
when the alkyl chain is greater than eight carbons. The driving force for assembly into 
micelles is mediated by free energy and hindered by the energy required for nucleation and 
steric effects.40  
The CMC was correlated with drug loading (R = -0.58) and release (R = 0.73 for pH 
7.4 and R = 0.83 for pH 5). Lower CMCs indicate enthalpic or hydrophobic dominated 
micelle assembly, which can compensate for the free energy required for micelle formation 
and result in micelle stability.40 For lower CMCs, the surfactant has a higher tendency to 
form micelles, generally leading to higher loading capacity and a lower release rate.45 Similar 
to the CMC trends, drug release at pH 5 and 7.4 was found to increase with PEG chain length 
while loading showed a negative relationship with drug release. This can also be explained 
by micelle stability. Unlike the CMC, both drug release and loading do not exhibit strong 
linear relationships to alkyl chain length. This could result from the peak or inflection point 
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observed in figure 17C. There also could be odd-even effects as Ppeg-1000-hex, -oct, and -
dec had much higher drug release than other polymers at pH 7.4 (Fig. 18E). The odd-even 
effect is known to change the dipole force tilt angle and could alter chain orientation inside 
the micelle core.268 Such an effect could be magnified when the micelle is loaded with 
pyrene, which has conjugated pi bonds.  
While cell viability was not linearly correlated with the descriptors or observables 
measured here, cell internalization was positively correlated with PEG molecular weight (R = 
0.87) and was not correlated with alkyl chain length (R = -0.18). Since the length of PEG is 
related to its hydrogen bonding capability, and this is known to influence macrophage 
internalization,242 this result was expected. Furthermore, the alkyl chain is in the interior of 
the particle and would not be expected to interact with the cell at concentrations above the 
CMC. 
The empirical formulas in equations 4-6 illustrate the individual effects of PEG chain 
length (x), alkyl chain length (y), and the HLB value (z) as well as the interaction between 
these three variables on drug loading, drug release, and particle internalization. From these 
equations, the individual effect of these descriptors was found to be much higher than the 
linear combination of these descriptors on the observables. Cell internalization, surprisingly, 
exhibited a high R2 value and had a good distribution of data points (Fig. 21B). To further 
examine our model for drug delivery behavior, Ppeg-600-und and Ppeg-1000-dec were 
synthesized with different alkyl modification ratios. The resultant polymers were Ppeg-600-
und-91 and Ppeg-1000-dec-72, which had 91% and 72% of the hydroxyl on the isophthalate 
modified with the alkyl chains, respectively. By changing the alkyl modification ratio, we 
could adjust the HLB value without varying the PEG and alkyl chain length. These polymers 
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were characterized using the same techniques as were employed for the original set of 
materials (Table 2). The two polymers were found to fit with our predictions (Fig. 21B, red 
data points). This model, or factorial analysis in general, may have applicability in other 
hydrophilic-hydrophobic altering copolymer drug delivery systems. 
Conclusions  
Here, Ppeg-600/1000 micelles with varying alkyl chain length biosurfactants were 
studied to investigate the effect of hydrophobic/hydrophilic chain length on drug delivery 
systems. Key factors such as the CMC and drug loading and release properties can be 
programmed by varying PEG or alkyl chain lengths while having negligible effects on 
micelle size and small effects on the zeta potential. The CMC was reduced to 0.004 wt% for 
some of the materials and the particles could complex with pyrene, with a loading capacity 
up to 8 wt% of the polymer. Ppeg-600-alkane particles could retard drug release to less than 
20% of the loaded pyrene after 96 h. Cell internalization of the particles was tested both 
quantitatively and qualitatively. Pyrene displayed no detectable internalization by the cells, 
but could be internalized when encapsulated in the polymeric micelles. One of the polymers, 
Ppeg-1000-nonane, reduced cell viability when delivering pyrene. Cell internalization was 
found to depend mainly on PEG chain length. Empirical equations for drug loading/release 
and cell internalization were derived as a function of PEG and alkyl molecular weight and 
the HLB value, which were subsequently validated by synthesizing copolymers with 
different HLB values. These results show the utility of factorial analysis in predicting drug 
delivery parameters for micelle structures.  
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APPENDIX A. SUMMRY OF MACROPHAGES AND FIBROBLASTS RESPONSE ON BIOIMPLANT 
Material Implant Site Macrophage effect Fibroblast effect 
Alginate 
hydrogel 
In vitro106–
109,220,269 
G/M ratio dependence G/M ratio dependence 
Reduce efferocytosis in LPS activated M1  
High MW leads to M2 response Reduced myofibroblast with increased dosage 
Enzymatic degradation product leads to M1  
Oxidative degradation product reduces LPS 
activated M1 
 
Divalent ion free hydrogel leads to reduced M1 
response 
 
 
Abdominal 
wall270 
Lower stiffness has higher cell infiltration  
Skin271 IL-10 plasmid leads to M2  
Intraperitoneal272 M2 activation 
Increased myofibroblast differentiation + 
fibrotic response 
Bleomycin Lung273,274 Hemosiderin staining 
Increased myofibroblast differentiation for 
stiff substrates 
Chitosan 
In 
vitro118,121,131,132 
DD dependent Reduced myofibroblasts 
Enhanced fibroblast viability 
 
MW dependent M1 response 
Increased mobility 
Enzymatic degradation products lead to M1 
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113 
 
Intraperitoneal139 Increased M1 response Reduced myofibroblast differentiation + 
fibrotic response 
Knee trochlea136 
 
Reduced myofibroblast differentiation + 
fibrotic response 
Skin140 No significant difference No significant difference 
Chondroitin 
Intraspinal275,276 Chondroitinase ABC leads to M2 response 
 
In vitro277,278 
Chondroitin-6-sulfate reduces LPS induced M1 
response 
 
Collagen Skin279 M2 and M0 response 
 
Dermatan 
sulfate 
Skin102 
Reduced macrophage population in 
inflammation 
Reduced myofibroblast population in 
inflammation 
ECM 
scaffolds 
In vitro280,281 
Brain ECM leads to M1 response Enhanced skeletal muscle myoblasts 
Enzymatic degradation products lead to M2 
response 
 
Abdominal 
wall282,283 
Acellular ECM has high cell infiltration in early 
stages followed by M2 response, ECM leads to 
M1 
 
Hyaluronic 
acid 
Heart284 Possibly both M1 and M2 Positive FBR + decreased fibrosis over 7 days 
In vitro145,146,151 
High sulfation leads to M2 High sulfation increases fibroblast adhesion 
Low MW leads to M1 Low MW-increases myofibroblasts 
High MW leads to M2 High MW-decreases myofibroblasts 
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114 
 
Keratin 
In vitro285 M2 
 
Eye286 Higher inflammation than amniotic membrane 
 
Conduit lumen287 Reduced macrophage number 
 
Silk 
In vitro190 Reduce M1 with silk source dependence  
Bones188 
Differentiation into FBGCs and infiltrating 
macrophages 
Osteogenic differentiation of hMSCs into 
osteoblasts 
Skin103,104 
Reduced macrophage number and inflammatory 
response 
Reduced myofibroblast differentiation and 
fibrotic response 
Macrophage differentiation inhibited 
 
114 
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APPENDIX B. NMR SPECTRA OF THE POLYMERS 
The serial number of protons listed below corresponds to Figure 16.  
 
 
116 
 
 
 
 
a) Poly[(poly(oxyethylene-600)-oxy-5-hydroxyisophthaloyl] (Ppeg-600) 1H NMR data (in 
D2O): 3.67-3.79 (PEG main chain), 3.85 (H-4), 3.98 (H-7), 4.55 (H-3), 7.58-7.77 (H-2), 8.11 
(H-1);  
b) Poly[(poly(oxyethylene-1000)-oxy-5-hydroxyisophthaloyl] (Ppeg-1000) 1H NMR data (in 
D2O): 3.67-3.80 (PEG main chain), 3.83 (H-4), 3.98 (H-7), 4.54 (H-3), 7.63-7.82 (H-2), 8.27 
(H-1);  
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c) Poly[(polyoxyethylene-600)-oxy-5-(hexane)-isophthaloyl] (Ppeg-600-hex) 1H NMR data 
(in D2O): 0.95(H-6), 1.35(alkyl chain), 3.71-3.83 (PEG main chain), 3.92 (H-4 and H-8), 
4.50 (H-3), 7.40-7.48 (H-2), 8.02 (H-1);  
d) Poly[(polyoxyethylene-600)-oxy-5-(heptane)-isophthaloyl] (Ppeg-600-hep) 1H NMR data 
(in D2O): 0.88 (H-6), 1.38(alkyl chain), 3.68-3.77 (PEG main chain), 3.77-3.99 (H-4 and H-
8), 4.53 (H-3), 7.42-7.70 (H-2), 8.03 (H-1);  
e) Poly[(polyoxyethylene-600)-oxy-5-(octane)-isophthaloyl] (Ppeg-600-oct) 1H NMR data 
(in D2O): 0.91(H-6), 1.30(alkyl chain), 3.67-3.75 (PEG main chain), 3.89-3.99 (H-4 and H-
8), 4.47 (H-3), 7.45-7.78 (H-2), 7.96 (H-1);   
f) Poly[(polyoxyethylene-600)-oxy-5-(nonane)-isophthaloyl] (Ppeg-600-non) 1H NMR data 
(in D2O): 0.94(H-6), 1.33(alkyl chain), 3.68-3.76 (PEG main chain), 3.97 (H-4 and H-8), 
4.45 (H-3), 7.44-7.78 (H-2), 7.98 (H-1);  
g) Poly[(polyoxyethylene-600)-oxy-5-(decane)-isophthaloyl] (Ppeg-600-dec) 1H NMR data 
(in D2O): 0.94(H-6), 1.31(alkyl chain), 3.56-3.82 (PEG main chain), 3.90 (H-4 and H-8), 
4.49 (H-3), 7.51-7.87 (H-2), 7.98 (H-1);  
h) Poly[(polyoxyethylene-600)-oxy-5-(undecane)-isophthaloyl] (Ppeg-600-und) 1H NMR 
data (in D2O): 0.93(H-6), 1.31(alkyl chain), 3.62-3.80 (PEG main chain), 3.91 (H-4 and H-8), 
4.48 (H-3), 7.51-7.84 (H-2), 8.01 (H-1);  
i) Poly[(polyoxyethylene-1000)-oxy-5-(hexane)-isophthaloyl] (Ppeg-1000-hex) 1H NMR 
data (in D2O): 0.90(H-6), 1.30(alkyl chain), 3.69-3.78 (PEG main chain), 3.88-3.96 (H-4 and 
H-8), 4.53(H-3), 7.49-7.60(H-2), 8.03(H-1);  
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j) Poly[(polyoxyethylene-1000)-oxy-5-(heptane)-isophthaloyl] (Ppeg-1000-hep) 1H NMR 
data (in D2O): 0.90(H-6), 1.31(alkyl chain), 3.69-3.78 (PEG main chain), 3.78-3.97 (H-4 and 
H-8), 4.53 (H-3), 7.50-7.69 (H-2), 8.04 (H-1);  
k) Poly[(polyoxyethylene-1000)-oxy-5-(octane)-isophthaloyl] (Ppeg-1000-oct) 1H NMR data 
(in D2O): 0.90(H-6), 1.33(alkyl chain), 3.68-3.76 (PEG main chain), 3.89-4.00 (H-4 and H-
8), 4.45 (H-3), 7.44-7.78 (H-2), 7.98 (H-1);  
l) Poly[(polyoxyethylene-1000)-oxy-5-(nonane)-isophthaloyl] (Ppeg-1000-non) 1H NMR 
data (in D2O): 0.89(H-6), 1.28(alkyl chain), 3.62-3.77 (PEG main chain), 3.83-3.94 (H-4 and 
H-8), 4.53 (H-3), 7.49-7.81 (H-2), 8.02 (H-1) 
m) Poly[(polyoxyethylene-1000)-oxy-5-(decane)-isophthaloyl] (Ppeg-1000-dec) 1H NMR 
data (in D2O): 0.96(H-6), 1.34(alkyl chain), 3.72-3.78 (PEG main chain), 3.92 (H-4 and H-8), 
4.49 (H-3), 7.5 (H-2), 8.03 (H-1) 
n) Poly[(polyoxyethylene-1000)-oxy-5-(undecane)-isophthaloyl] (Ppeg-1000-und) 1H NMR 
data (in D2O): 0.96(H-6), 1.34(alkyl chain), 3.64-3.82 (PEG main chain), 3.91 (H-4 and H-8), 
4.49 (H-3), 7.52 (H-2), 8.04 (H-1) 
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APPENDIX C. COLD BINDING IMAGES 
Optical microscopy images of pyrene-loaded micelles incubated with RAW 264.7 
macrophages. Cells were incubated for 4 h at 4°C with the pyrene (blue) loaded micelles. 
The scale bar represents 100 μm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Ppeg-600-hexane Ppeg-600-heptane Ppeg-600-octane 
Ppeg-600-nonane Ppeg-600-decane Ppeg-600-undecane 
Ppeg-1000-hexane Ppeg-1000-heptane Ppeg-1000-octane 
Ppeg-1000-nonane Ppeg-1000-decane Ppeg-1000-undecane 
Pyrene 
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APPENDIX D. CHARACTERIZATION RESULTS OF PPEG-600/1000-ALKANE 
POLYMERS 
Micelle size, HLB value, and % hydroxyl modification with alkyl chain were measured. 
Errors are given as standard deviations.  
Ppeg Modification % HLB 
Micelle diameter 
(nm) 
600-hex 49±4 16.4 12.4±6.7 
600-hep 46±3 16.3 8.6±3.2 
600-oct 52±2 16.0 9.5±3.2 
600-non 68±1 15.4 12.7±6.9 
600-dec 43±1 16.0 9.0±2.3 
600-und 52±2 15.5 9.5±2.4 
1000-hex 52±5 17.6 18.5±9.3 
1000-hep 53±7 17.5 10.9±4.7 
1000-oct 59±1 17.3 15.7±9.0 
1000-non 46±1 17.4 17.3±10.7 
1000-dec 47±1 17.3 9.6±3.2 
1000-und 52±3 17.1 10.0±2.9 
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APPENDIX E. KINETIC COEFFICIENTS FOR DRUG RELEASE  
Drug release rates were modeled using a general release equation. k is release rate constant 
and n is release order coefficient. Errors are given as standard deviations.   
Ppeg 
k*103 n 
pH 7.4 pH 5 pH 7.4 pH 5 
600-hex 33.6±3.3 7.0±0.7 0.33±0.02 0.33±0.02 
600-hep 13.4±1.9 11.2±1.6 0.26±0.04 0.32±0.03 
600-oct 5.9±0.7 2.2±0.3 0.34±0.03 0.36±0.03 
600-non 32.5±5.7 4.3±1.5 0.22±0.05 0.38±0.08 
600-dec 8.7±1.4 13.7±0.0 0.51±0.03 0.38±0.01 
600-und 34.0±1.8 3.0±0.5 0.23±0.01 0.56±0.04 
1000-hex 167.9±22.4 18. 8±3.9 0.35±0.03 0.49±0.05 
1000-hep 120.8±27.6 45.9±10.3 0.25±0.05 0.37±0.05 
1000-oct 97.6±7.7 78.5±15.2 0.43±0.02 0.33±0.04 
1000-non 108.7±18.6 32.4±5.8 0.33±0.04 0.25±0.04 
1000-dec 212.5±15.0 0.2±0.1 0.26±0.02 1.13±0.11 
1000-und 8.5±1.1 1.5±0.5 0.43±0.03 0.65±0.07 
 
 
